TY 2018 Form 990

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)
(1) Bill Roedy...................................................................... Chairman of the Board	1.0 ................. 0.0	X	X	0	0
(2) Cindy Rachofsky...................................................................... Vice Chairman	1.0 ................. 0.0	X	X	0	0
(3) Arlen H Andelson...................................................................... Secretary	1.0 ................. 0.0	X	X	0	0
(4) Raymond F Schinazi PhD...................................................................... Treasurer (As of 03/19)	1.0 ................. 0.0	X	X	0	0
(5) Michael J Klingensmith...................................................................... Treasurer (Thru 03/19)	1.0 ................. 0.0	X	X	0	0
(6) David Bohnett...................................................................... Trustee	1.0 ................. 0.0	X		0	0
(7) Zev Braun...................................................................... Trustee (NON-VOTING)	1.0 ................. 0.0	X		0	0
(8) Jonathan S Canno...................................................................... Trustee (Thru 02/19)	1.0 ................. 0.0	X		0	0
(9) Jay Ellis...................................................................... Trustee	1.0 ................. 0.0	X		0	0
(10) Aileen Getty...................................................................... Trustee	1.0 ................. 0.0	X		0	0
(11) T Ryan Greenwalt...................................................................... Trustee (as of 2/19)	1.0 ................. 0.0	X		0	0
(12) Michele V McNeill PharmD...................................................................... Trustee (NON-VOTING)	1.0 ................. 0.0	X		0	0
(13) Edward Milstein...................................................................... Trustee	1.0 ................. 0.0	X		0	0
(14) Alan D Schwartz...................................................................... Trustee	1.0 ................. 0.0	X		0	0
(15) Mario Stevenson...................................................................... Trustee	1.0 ................. 0.0	X		0	0
(16) Phill Wilson...................................................................... Trustee (as of 2/19)	1.0 ................. 0.0	X		0	0
(17) Kevin Frost...................................................................... Chief Executive Officer	40.0 ................. 0.0		X	480,408	93,432

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(18) Bradley Jensen........................................................................ Assistant Treasurer, CFO	40.0 .......................0.0	X			268,290	0	62,167
(19) Rowena Johnston........................................................................ ASST SEC, VP, RESEARCH	40.0 .......................0.0	X			207,188	0	32,709
(20) Edward Donnelly........................................................................ Asst Treasurer, Controller	40.0 .......................0.0	X			165,914	0	33,007
(21) Eric Muscatell........................................................................ Vice President of Development	40.0 .......................0.0		X		219,278	0	34,529
(22) Annette Sohn........................................................................ Vice President, TREAT Asia PGM	40.0 .......................0.0		X		235,284	0	25,131
(23) AnnMarie Shannahan........................................................................ Vice President, Public Info.	40.0 .......................0.0		X		237,680	0	45,538
(24) Gregorio Millet........................................................................ Vice President, Public Policy	40.0 .......................0.0		X		186,211	0	56,072
(25) Andrew McInness........................................................................ Director, Publications	40.0 .......................0.0			X	170,102	0	67,984
(26) Anthony Ancona........................................................................ Vice President, Human Resource	40.0 .......................0.0			X	192,931	0	31,716
(27) Susan Doster........................................................................ Chief Technology Officer	40.0 .......................0.0			X	149,888	0	52,030
(28) JONATHAN KEY........................................................................ DIRECTOR, PHILANTHROPY	40.0 .......................0.0			X	193,887	0	57,103
(29) Sebastian Gheith........................................................................ Associate Counsel	40.0 .......................0.0			X	169,030	0	67,978

(A) Name and business address	(B) Description of services	(C) Compensation
AAB PRODUCTION INC, 64 ALLEN ROAD 5TH FLOOR NEW YORK,NY10002	Events Production	623,887
PATTERSON BELKNAP WEBB TYLER LLP, 1133 Avenue of the Americas NEW YORK,NY100366710	LEGAL SERVICES	512,837
JOSH WOODS PRODUCTION, 39 WEST 14TH STREET SUITE 504 NEW YORK,NY10011	Events Production	315,500
EIDOLON COMMUNICATIONS INC, 15 MAIDEN LANE SUITE 1401 NEW YORK,NY10038	DIRECT MAIL/CONSULT.	286,181
INCA INTERNATIONAL PRODUCTIONS INC, 40 WORTH STREET SUITE 827 NEW YORK,NY10013	Events Production	284,783
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 13

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow

Attach to Form 990 or Form 990-EZ.
right arrow

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E (Form 990 or 990-EZ).)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An agricultural research organization described in 170(b)(1)(A)(ix) operated in conjunction with a land-grant college or university or a non-land grant college of agriculture. See instructions. Enter the name, city, and state of the college or university:

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box in lines 12a through 12d that describes the type of supporting organization and complete lines 12e, 12f, and 12g.

Type I. A supporting organization operated, supervised, or controlled by its supported organization(s), typically by giving the supported organization(s) the power to regularly appoint or elect a majority of the directors or trustees of the supporting organization. You must complete Part IV, Sections A and B.

Type II. A supporting organization supervised or controlled in connection with its supported organization(s), by having control or management of the supporting organization vested in the same persons that control or manage the supported organization(s). You must complete Part IV, Sections A and C.

Type III functionally integrated. A supporting organization operated in connection with, and functionally integrated with, its supported organization(s) (see instructions). You must complete Part IV, Sections A, D, and E.

Type III non-functionally integrated. A supporting organization operated in connection with its supported organization(s) that is not functionally integrated. The organization generally must satisfy a distribution requirement and an attentiveness requirement (see instructions). You must complete Part IV, Sections A and D, and Part V.

Check this box if the organization received a written determination from the IRS that it is a Type I, Type II, Type III functionally integrated, or Type III non-functionally integrated supporting organization.

Enter the number of supported organizations ...............................

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization listed in your governing document?		(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)
(i) Name of supported organization	(ii) EIN	Yes	No	(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)


Total

For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2018

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv), 170(b)(1)(A)(vi), and 170(b)(1)(A)(ix)
(Complete only if you checked the box on line 5, 7, 8, or 9 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") ..	56,251,128	58,810,206	50,842,378	42,784,390	40,275,703	248,963,805
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....						0
3	The value of services or facilities furnished by a governmental unit to the organization without charge..						0
4	Total. Add lines 1 through 3	56,251,128	58,810,206	50,842,378	42,784,390	40,275,703	248,963,805
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						0
6	Public support. Subtract line 5 from line 4.						248,963,805

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
7	Amounts from line 4..	56,251,128	58,810,206	50,842,378	42,784,390	40,275,703	248,963,805
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	1,652,775	1,316,372	1,354,513	1,590,672	1,538,331	7,452,663
9	Net income from unrelated business activities, whether or not the business is regularly carried on..						0
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.)..	2,103,589	2,246,081	1,819,001	2,097,498	1,822,760	10,088,929
11	Total support. Add lines 7 through 10						266,505,397

Gross receipts from related activities, etc. (see instructions) ..................

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2018 (line 6, column (f) divided by line 11, column (f)) .........

93.418 %

Public support percentage for 2017 Schedule A, Part II, line 14 ...............

93.335 %

16a

33 1/3% support test—2018. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2017. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2018. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2017. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2018

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose
3	Gross receipts from activities that are not an unrelated trade or business under section 513 .....
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge
6	Total. Add lines 1 through 5
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support. (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2018 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2017 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2018 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2017 Schedule A, Part III, line 17 .............

19a

331/3% support tests—2018. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ....... right arrow

33 1/3% support tests—2017. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization .... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions .... right arrow

Schedule A (Form 990 or 990-EZ) 2018

Page 4

Part IV

Supporting Organizations

(Complete only if you checked a box on line 12 of Part I. If you checked 12a of Part I, complete Sections A and B. If you checked 12b of Part I, complete Sections A and C. If you checked 12c of Part I, complete Sections A, D, and E. If you checked 12d of Part I, complete Sections A and D, and complete Part V.)

Section A. All Supporting Organizations

Yes

Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.

Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).

Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.

Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.

Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.

Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 12a or 12b in Part I, answer (b) and (c) below.

Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.

Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.

Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).

Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?

Substitutions only. Was the substitution the result of an event beyond the organization's control?

Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.

Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .

Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).

Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.

Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.

Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.

10a

Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.

10a

Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).

10b

Schedule A (Form 990 or 990-EZ) 2018

Page 5

Part IV

Supporting Organizations (continued)

Yes

Has the organization accepted a gift or contribution from any of the following persons?

A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?

11a

A family member of a person described in (a) above?

11b

A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.

11c

Section B. Type I Supporting Organizations

Yes

Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.

Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.

Section C. Type II Supporting Organizations

Yes

Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).

Section D. All Type III Supporting Organizations

Yes

Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?

Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).

By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.

Section E. Type III Functionally-Integrated Supporting Organizations

Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):

The organization satisfied the Activities Test. Complete line 2 below.

The organization is the parent of each of its supported organizations. Complete line 3 below.

The organization supported a governmental entity. Describe in Part VI how you supported a government entity (see instructions)

Activities Test. Answer (a) and (b) below.

Yes

Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.

Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.

Parent of Supported Organizations. Answer (a) and (b) below.

Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.

Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.

Schedule A (Form 990 or 990-EZ) 2018

Page 6

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations

Check here if the organization satisfied the Integral Part Test as a qualifying trust on Nov. 20, 1970 (explain in Part VI). See instructions. All other Type III non-functionally integrated supporting organizations must complete Sections A through E.

	Section A - Adjusted Net Income		(A) Prior Year	(B) Current Year (optional)
1	Net short-term capital gain	1
2	Recoveries of prior-year distributions	2
3	Other gross income (see instructions)	3
4	Add lines 1 through 3	4
5	Depreciation and depletion	5
6	Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions)	6
7	Other expenses (see instructions)	7
8	Adjusted Net Income (subtract lines 5, 6 and 7 from line 4)	8

	Section B - Minimum Asset Amount		(A) Prior Year	(B) Current Year (optional)
1	Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year):	1
a	Average monthly value of securities	1a
b	Average monthly cash balances	1b
c	Fair market value of other non-exempt-use assets	1c
d	Total (add lines 1a, 1b, and 1c)	1d
e	Discount claimed for blockage or other factors (explain in detail in Part VI):
2	Acquisition indebtedness applicable to non-exempt use assets	2
3	Subtract line 2 from line 1d	3
4	Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions).	4
5	Net value of non-exempt-use assets (subtract line 4 from line 3)	5
6	Multiply line 5 by .035	6
7	Recoveries of prior-year distributions	7
8	Minimum Asset Amount (add line 7 to line 6)	8

	Section C - Distributable Amount		Current Year
1	Adjusted net income for prior year (from Section A, line 8, Column A)	1
2	Enter 85% of line 1	2
3	Minimum asset amount for prior year (from Section B, line 8, Column A)	3
4	Enter greater of line 2 or line 3	4
5	Income tax imposed in prior year	5
6	Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions)	6

Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions)

Schedule A (Form 990 or 990-EZ) 2018

Page 7

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations (continued)

Section D - Distributions		Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity
3 Administrative expenses paid to accomplish exempt purposes of supported organizations
4 Amounts paid to acquire exempt-use assets
5 Qualified set-aside amounts (prior IRS approval required)
6 Other distributions (describe in Part VI). See instructions
7Total annual distributions. Add lines 1 through 6.
8 Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions
9 Distributable amount for 2018 from Section C, line 6
10 Line 8 amount divided by Line 9 amount

Section E - Distribution Allocations (see instructions)		(i) Excess Distributions	(ii) Underdistributions Pre-2018	(iii) Distributable Amount for 2018
1 Distributable amount for 2018 from Section C, line 6
2 Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI). See instructions.
3 Excess distributions carryover, if any, to 2018:
a From 2013.......
b From 2014.......
c From 2015.......
d From 2016.......
e From 2017.......
fTotal of lines 3a through e
g Applied to underdistributions of prior years
h Applied to 2018 distributable amount
i Carryover from 2013 not applied (see instructions)
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.
4Distributions for 2018 from Section D, line 7:
$
a Applied to underdistributions of prior years
b Applied to 2018 distributable amount
c Remainder. Subtract lines 4a and 4b from 4.
5 Remaining underdistributions for years prior to 2018, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions.
6 Remaining underdistributions for 2018. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions.
7 Excess distributions carryover to 2019. Add lines 3j and 4c.
8 Breakdown of line 7:
a Excess from 2014......
b Excess from 2015.....
c Excess from 2016.....
d Excess from 2017.....
e Excess from 2018.....

Schedule A (Form 990 or 990-EZ) (2018)

Schedule A (Form 990 or 990-EZ) 2018

Page 8

Part VI

Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Return Reference	Explanation

Schedule A (Form 990 or 990-EZ) 2018

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, contributions totaling $5,000 or more (in money or other property) from any one contributor. Complete Parts I and II. See instructions for determining a contributor's total contributions.

Special Rules

For an organization described in section 501(c)(3) filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi), that checked Schedule A (Form 990 or 990-EZ), Part II, line 13, 16a, or 16b, and that received from any one contributor, during the year, total contributions of the greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 exclusively for religious, charitable, scientific, literary, or educational purposes, or for the prevention of cruelty to children or animals. Complete Parts I, II, and III.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions exclusively for religious, charitable, etc., purposes, but no such contributions totaled more than $1,000. If this box is checked, enter here the total contributions that were received during the year for an exclusively religious, charitable, etc., purpose. Don't complete any of the parts unless the General Rule applies to this organization because it received nonexclusively religious, charitable, etc., contributions totaling $5,000 or more during the year ......... Arrow Bullet

Caution. An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2018)

Schedule B (Form 990, 990-EZ, or 990-PF) (2018) Page 2

Name of organization THE FOUNDATION FOR AIDS RESEARCH

Part I	Contributors (See instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	,	$ RESTRICTED	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Page 3

Name of organization THE FOUNDATION FOR AIDS RESEARCH		Employer identification number 13-3163817

Part II	Noncash Property (See instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Page 4


Name of organization THE FOUNDATION FOR AIDS RESEARCH			Employer identification number 13-3163817
Part III Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) $ Use duplicate copies of Part III if additional space is needed.

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV (see instructions for definition of “political campaign activities")

Political campaign activity expenditures (see instructions) .................................................................... SchCMd Bullet

Volunteer hours for political campaign activities (see instructions) ..................................................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ................................ SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ....................... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................

Yes No

Was a correction made? ......................................................................................................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................ SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b........... SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ...................................................................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6

For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.

Cat. No. 50084S

Schedule C (Form 990 or 990-EZ) 2018

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......................
b	Total lobbying expenditures to influence a legislative body (direct lobbying) ...............................
c	Total lobbying expenditures (add lines 1a and 1b) ...................................................................
d	Other exempt purpose expenditures ........................................................................
e	Total exempt purpose expenditures (add lines 1c and 1d) ...............................................
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................................................
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ...................................................................................................................	Yes No

4-Year Averaging Period Under section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2015	(b) 2016	(c) 2017	(d) 2018	(e) Total

2a	Lobbying nontaxable amount

b	Lobbying ceiling amount (150% of line 2a, column(e))

c	Total lobbying expenditures

d	Grassroots nontaxable amount

e	Grassroots ceiling amount (150% of line 2d, column (e))

f	Grassroots lobbying expenditures

Schedule C (Form 990 or 990-EZ) 2018

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? ...........................................................................................................

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........

Yes

Media advertisements? ...................................................................................................

Mailings to members, legislators, or the public? .............................................................................

Publications, or published or broadcast statements? ...........................................................

Grants to other organizations for lobbying purposes? ..........................................................

Direct contact with legislators, their staffs, government officials, or a legislative body? .......................

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................

Other activities? ...................................................................................................................

Yes

391,838

Total. Add lines 1c through 1i ....................................................................................................

391,838

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 ...........................................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ...............................................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................

Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members ......................................................................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).

Current year .............................................................................................................................

Carryover from last year ............................................................................................................

Total ...........................................................................................................................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................

Taxable amount of lobbying and political expenditures (see instructions) .........................................

Part IV

Supplemental Information

Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.

Return Reference	Explanation
LOBBYING EXPENSES	PART II-B THE FOUNDATION FOR AIDS RESEARCH DEVELOPED AN ACTION AGENDA TO END AIDS THAT IDENTIFIED CRITICAL DECISIONS THAT NEED TO BE MADE TO ADVANCE EVIDENCE BASED AIDS POLICIES. WE CREATED A VARIETY OF ISSUE BRIEFS ON TOPICS SUCH AS THE POTENTIAL IMPACT OF VARIOUS BUDGET SCENARIOS ON GLOBAL HEALTH SERVICES, AND POLICY PRIORITIES TO ADDRESS THE HIV EPIDEMIC AMONG GAY MEN IN THE US. THESE ISSUE BRIEFS WERE SHARED WITH CAPITOL HILL STAFF AND MEMBERS OF THE ADMINISTRATION. AMFAR MET REGULARLY WITH STAFF TO MEMBERS OF CONGRESS AND WITH ADMINISTRATION STAFF, AND WE PROVIDED INPUT TO THE ADMINISTRATION ON DEVELOPMENT OF THE PEPFAR BLUEPRINT FOR AN AIDS FREE GENERATION. AMFAR SPONSORED SEVERAL BRIEFINGS ON CAPITOL HILL ON AIDS POLICY AND RESEARCH ISSUES. AMFAR USES THESE BRIEFINGS AS AN EDUCATIONAL TOOL. The Foundation engaged an independent consultant to engage in lobbying activities on its behalf. Fees paid to this consultant totaled $123,466 in the fiscal year ending September 30, 2019.

Return Reference

Explanation

LOBBYING EXPENSES

PART II-B THE FOUNDATION FOR AIDS RESEARCH DEVELOPED AN ACTION AGENDA TO END AIDS THAT IDENTIFIED CRITICAL DECISIONS THAT NEED TO BE MADE TO ADVANCE EVIDENCE BASED AIDS POLICIES. WE CREATED A VARIETY OF ISSUE BRIEFS ON TOPICS SUCH AS THE POTENTIAL IMPACT OF VARIOUS BUDGET SCENARIOS ON GLOBAL HEALTH SERVICES, AND POLICY PRIORITIES TO ADDRESS THE HIV EPIDEMIC AMONG GAY MEN IN THE US. THESE ISSUE BRIEFS WERE SHARED WITH CAPITOL HILL STAFF AND MEMBERS OF THE ADMINISTRATION. AMFAR MET REGULARLY WITH STAFF TO MEMBERS OF CONGRESS AND WITH ADMINISTRATION STAFF, AND WE PROVIDED INPUT TO THE ADMINISTRATION ON DEVELOPMENT OF THE PEPFAR BLUEPRINT FOR AN AIDS FREE GENERATION. AMFAR SPONSORED SEVERAL BRIEFINGS ON CAPITOL HILL ON AIDS POLICY AND RESEARCH ISSUES. AMFAR USES THESE BRIEFINGS AS AN EDUCATIONAL TOOL. The Foundation engaged an independent consultant to engage in lobbying activities on its behalf. Fees paid to this consultant totaled $123,466 in the fiscal year ending September 30, 2019.

Schedule C (Form 990 or 990EZ) 2018

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet

Attach to Form 990.
SchDMd Bullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate value of contributions to (during year)
3	Aggregate value of grants from (during year)
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" on Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements ......................	2a
b	Total acreage restricted by conservation easements ....................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ...	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenue included on Form 990, Part VIII, line 1 ......................... SchDMd Bullet

(ii)

Assets included in Form 990, Part X ............................... SchDMd Bullet

$ 459,230

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenue included on Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2018

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other Donated Items, Inventory etc.

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No


b	If "Yes," explain the arrangement in Part XIII and complete the following table:		Amount
c	Beginning balance .............................	1c
d	Additions during the year ............................	1d
e	Distributions during the year ..........................	1e
f	Ending balance ................................	1f

Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...

Yes No

If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....

Part V

Endowment Funds. Complete if the organization answered "Yes" on Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	(c)Two years back	(d)Three years back	(e)Four years back

1a	Beginning of year balance ....	684,111	593,133	541,231	493,036	490,979
b	Contributions ...	6,750	4,100	5,950	7,293	7,998
c	Net investment earnings, gains, and losses	10,507	86,877	45,952	40,902	-5,941
d	Grants or scholarships ...
e	Other expenditures for facilities and programs ...
f	Administrative expenses ....
g	End of year balance ......	701,368	684,110	593,133	541,231	493,036

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

Permanent endowment SchDMd Bullet

54.080 %

Temporarily restricted endowment SchDMd Bullet

45.920 %

The percentages on lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations .................

3a(i)

(ii) related organizations .................

3a(ii)

If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.

Description of property		(a) Cost or other basis (investment)	(b) Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value

1a	Land .....
b	Buildings ....
c	Leasehold improvements	2,542,490	585,427	1,957,063
d	Equipment ....	304,826	303,430	1,396
e	Other .....	4,450,732	3,608,379	842,353
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..				2,800,812

Schedule D (Form 990) 2018

Page 3

Part VII

InvestmentsOther Securities. Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)	(b) Book value	(c) Method of valuation: Cost or end-of-year market value
(1) Financial derivatives.........
(2) Closely-held equity interests........
(3)Other
(A)
(B)
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

InvestmentsProgram Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.

(a) Description of investment	(b) Book value	(c) Method of valuation: Cost or end-of-year market value

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.

(a) Description				(b) Book value

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........

Part X

Other Liabilities. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.

1.(a) Description of liability	(b) Book value
(1) Federal income taxes	0
LONG TERM LEASE LIABILITY	1,572,406
SEC. 457 RETIREMENT LIABILITY	296,980
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)	1,869,386
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII

Schedule D (Form 990) 2018

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total revenue, gains, and other support per audited financial statements .......			1	31,715,076
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains (losses) on investments ....	2a	564,696
b	Donated services and use of facilities .........	2b	87,894
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d	-1,455
e	Add lines 2a through 2d .....................			2e	651,135
3	Subtract line 2e from line 1..................			3	31,063,941
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a	277,449
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b....................			4c	277,449
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......			5	31,341,390

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total expenses and losses per audited financial statements ...........			1	34,781,194
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities .........	2a	87,894
b	Prior year adjustments ............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d	-1,455
e	Add lines 2a through 2d....................			2e	86,439
3	Subtract line 2e from line 1...................			3	34,694,755
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a	277,449
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.....................			4c	277,449
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......			5	34,972,204

Part XIII

Supplemental Information

Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Return Reference	Explanation
ENDOWMENTS	PART V, LINE 4 AMFAR'S ENDOWMENT FUND IS INTENDED TO FUND THE VARIOUS GENERAL RESEARCH PROGRAMS THE ORGANIZATION SPONSORS. Reconciliation of Revenue & Expenses Part XI & Part XII, Line 2d Loss/Gain on Disposal of Fixed Assets $-1,455
FIN 48 - INCOME TAXES	AMFAR FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND GUIDANCE ON MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE-LIKELY-THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. AMFAR IS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH IT IS SUBJECT TO TAX ON INCOME UNRELATED TO ITS EXEMPT PURPOSE, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE CODE. AMFAR HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. AMFAR HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS.
COLLECTIONS OF ART, HISTORICAL TREASURES, OR OTHER SIMILAR ASSETS	PART III, LINE 4 AMFAR HOLDS VARIOUS ITEMS OF JEWELRY, PHOTOGRAPHS AND OTHER ITEMS OF ARTISTIC VALUE THAT HAVE BEEN DONATED TO THE ORGANIZATION FOR SALE AT SPECIAL EVENTS. THE ORGANIZATION HAS MAINTAINED THESE ITEMS IN INVENTORY FOR A FEW YEARS AND IS IN THE PROCESS OF SELLING THEM.

Schedule D (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.

For grantmakers. Does the organization maintain records to substantiate the amount of its grants and

other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used

to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(b) Number of offices in the region	(c) Number of employees, agents, and independent contractors in region	(d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in region	(f) Total expenditures for and investments in region
	East Asia and the Pacific			Grantmaking	n/a	1,885,978
	Europe (Including Iceland and Greenland)			Grantmaking	N/A	1,031,960
	North America			Grantmaking	N/A	75,000
	South Asia			Grantmaking	N/A	63,568
	Sub-Saharan Africa			Grantmaking	N/A	174,161
	East Asia and the Pacific	1	15	Program Services	Therapeutics, Training	1,855,984
	East Asia and the Pacific			Fundraising	N/A	1,563,509
	Europe (Including Iceland and Greenland)			Fundraising	N/A	8,408,176
	South America			Fundraising	N/A	290,459








3a	Sub-total .....	1	15			15,348,795
b	Total from continuation sheets to Part I ...
c	Totals (add lines 3a and 3b)	1	15			15,348,795

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2018

Schedule F (Form 990) 2018

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(d) Purpose of grant	(e) Amount of cash grant	(f) Manner of cash disbursement
East Asia/Pacific	BASIC RESEARCH	249,961	wire transfe
East Asia/Pacific	BASIC RESEARCH	24,828	wire transfe
East Asia/Pacific	BASIC RESEARCH	37,500	wire transfe
East Asia/Pacific	GMT INITIATIVE	46,153	wire transfe
East Asia/Pacific	TREAT ASIA	31,251	wire transfe
East Asia/Pacific	TREAT ASIA	20,848	wire transfe
East Asia/Pacific	TREAT ASIA	6,245	wire transfe
East Asia/Pacific	TREAT ASIA	19,995	wire transfe
East Asia/Pacific	TREAT ASIA	14,925	wire transfe
East Asia/Pacific	TREAT ASIA	15,450	wire transfe
East Asia/Pacific	TREAT ASIA	9,861	wire transfe
East Asia/Pacific	TREAT ASIA	21,208	wire transfe
East Asia/Pacific	TREAT ASIA	16,700	wire transfe
East Asia/Pacific	TREAT ASIA	20,490	wire transfe
East Asia/Pacific	TREAT ASIA	22,686	wire transfe
East Asia/Pacific	TREAT ASIA	21,688	wire transfe
East Asia/Pacific	TREAT ASIA	21,582	wire transfe
East Asia/Pacific	TREAT ASIA	23,528	wire transfe
East Asia/Pacific	TREAT ASIA	20,993	wire transfe
East Asia/Pacific	TREAT ASIA	21,236	wire transfe
East Asia/Pacific	TREAT ASIA	15,570	wire transfe
East Asia/Pacific	TREAT ASIA	23,212	wire transfe
East Asia/Pacific	TREAT ASIA	21,368	wire transfe
East Asia/Pacific	TREAT ASIA	21,228	wire transfe
East Asia/Pacific	TREAT ASIA	79,383	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,350	wire transfe
East Asia/Pacific	TREAT ASIA	6,450	wire transfe
East Asia/Pacific	TREAT ASIA	6,150	wire transfe
East Asia/Pacific	TREAT ASIA	6,600	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,425	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	235,373	wire transfe
East Asia/Pacific	TREAT ASIA	199,262	wire transfe
East Asia/Pacific	TREAT ASIA	79,357	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	15,000	wire transfe
East Asia/Pacific	TREAT ASIA	14,988	wire transfe
East Asia/Pacific	TREAT ASIA	7,500	wire transfe
East Asia/Pacific	TREAT ASIA	24,500	wire transfe
East Asia/Pacific	TREAT ASIA	20,000	wire transfe
East Asia/Pacific	TREAT ASIA	10,705	wire transfe
East Asia/Pacific	TREAT ASIA	8,110	wire transfe
East Asia/Pacific	TREAT ASIA	7,154	wire transfe
East Asia/Pacific	TREAT ASIA	6,156	wire transfe
East Asia/Pacific	TREAT ASIA	7,928	wire transfe
East Asia/Pacific	TREAT ASIA	20,357	wire transfe
East Asia/Pacific	TREAT ASIA	7,820	wire transfe
East Asia/Pacific	TREAT ASIA	62,732	wire transfe
East Asia/Pacific	TREAT ASIA	9,242	wire transfe
East Asia/Pacific	TREAT ASIA	124,794	wire transfe
East Asia/Pacific	TREAT ASIA	8,999	wire transfe
East Asia/Pacific	TREAT ASIA	10,400	wire transfe
East Asia/Pacific	TREAT ASIA	7,900	wire transfe
East Asia/Pacific	TREAT ASIA	8,000	wire transfe
East Asia/Pacific	TREAT ASIA	5,832	wire transfe
East Asia/Pacific	TREAT ASIA	8,000	wire transfe
East Asia/Pacific	TREAT ASIA	8,000	wire transfe
East Asia/Pacific	TREAT ASIA	6,500	wire transfe
East Asia/Pacific	TREAT ASIA	5,625	wire transfe
Europe	BASIC RESEARCH	73,333	wire transfe
Europe	BASIC RESEARCH	45,000	wire transfe
Europe	RESEARCH	141,077	wire transfe
Europe	RESEARCH	365,143	wire transfe
Europe	RESEARCH	60,000	wire transfe
Europe	RESEARCH	429,468	wire transfe
North America (excl USA)	BASIC RESEARCH	75,000	wire transfe
South Asia	TREAT ASIA	19,078	wire transfe
South Asia	TREAT ASIA	19,974	wire transfe
South Asia	TREAT ASIA	7,500	wire transfe
South Asia	TREAT ASIA	17,016	wire transfe
Sub-Saharan Africa	BASIC RESEARCH	24,998	wire transfe
Sub-Saharan Africa	BASIC RESEARCH	24,698	wire transfe
Sub-Saharan Africa	BASIC RESEARCH	24,998	wire transfe
Sub-Saharan Africa	PUBLIC POLICY	30,000	wire transfe
Sub-Saharan Africa	TREAT ASIA	64,351	wire transfe
Sub-Saharan Africa	TREAT ASIA	5,041	wire transfe
Sub-Saharan Africa	TREAT ASIA	7,647	wire transfe

2	Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......	82
3	Enter total number of other organizations or entities .......................

Schedule F (Form 990) 2018

Schedule F (Form 990) 2018Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of non-cash assistance	(g) Description of non-cash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2018

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2018

Page 5

Part V

Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).

ReturnReference	Explanation
FOREIGN ACTIVITIES	PART I, LINE 2 INTERNATIONAL ORGANIZATIONS ARE RECOMMENDED FOR FUNDING BASED UPON THE RESULTS OF COMMUNITY-BASED PEER REVIEW AND/OR PROGRAM STAFF ASSESSMENT OF PROPOSAL MERIT AND ORGANIZATION CAPACITY TO UNDERTAKE PROPOSED PROJECTS THAT ARE CHARITABLE IN PURPOSE. PRE-AWARD DUE-DILIGENCE FOR NEW INTERNATIONAL GRANTEES INCLUDES REVIEW OF ORGANIZATION DOCUMENTS AND REGISTRATIONS TO VERIFY THAT THE ORGANIZATION OPERATES FOR A CHARITABLE PURPOSE AND THAT BASIC CAPACITY FOR PROJECT OVERSIGHT AND GOVERNANCE HAS BEEN ESTABLISHED. ALL INTERNATIONAL GRANTEES ARE REQUIRED TO REPORT SEMI-ANNUALLY ON PROJECT PROGRESS AND EXPENDITURES; CONTINUED REPORTING IS REQUIRED UNTIL SUCH TIME AS GRANT FUNDS ARE EXPENDED IN FULL. REPORTS ARE REVIEWED BY ADMINISTRATIVE AND PROGRAM STAFF. ADDITIONAL OVERSIGHT IS PROVIDED AS NECESSARY BY MEANS OF ONGOING, INFORMAL CONTACT WITH SITES REGARDING PROGRESS AND TECHNICAL ISSUES AND SITE VISITS WHERE FEASIBLE. INTERNATIONAL RESEARCH GRANT RECIPIENTS SUBMIT AN INTERIM AND A FINAL PROGRESS REPORTING ADDITION TO EXPENDITURES REPORTS DUE FOLLOWING THE ENDS OF THE 2ND, 3RD AND FINAL QUARTERS OF THE PERFORMANCE PERIOD.
FOREIGN ACTIVITIES	PART I, LINE 3, COLUMN D THE FOUNDATION FOR AIDS RESEARCH CONDUCTS MANY OF ITS GRANT-MAKING PROGRAM SERVICES (SEE PART III OF FORM 990) IN U.S. AND FOREIGN JURISDICTIONS. IN COLUMN D, THE ORGANIZATION HAS REPORTED THE BASIC PROGRAM THESE GRANTS SUPPORT; PLEASE REFER TO PART III FOR MORE INFORMATION ABOUT THESE PROGRAMS/INITIATIVES.
FOREIGN ACTIVITIES - STATUS OF GRANTEES	THE FOUNDATION FOR AIDS RESEARCH SUPPORTS MANY NON-U.S. ORGANIZATIONS IN THE FIGHT AGAINST AIDS AND HIV-RELATED DISEASES. FOR PURPOSES OF SCHEDULE F, PART II, LINE 2 - ALL 82 CHARITIES SUPPORTED ARE PRESUMED TO BE THE EQUIVALENT OF U.S. CHARITIES.

Schedule F (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE G (Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information Regarding
Fundraising or Gaming Activities

Complete if the organization answered "Yes" on Form 990, Part IV, lines 17, 18, or 19, or if the organization entered more than $15,000 on Form 990-EZ, line 6a. right arrow

Attach to Form 990 or Form 990-EZ.
right arrow

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Fundraising Activities. Complete if the organization answered "Yes" on Form 990, Part IV, line 17.

Form 990-EZ filers are not required to complete this part.

Indicate whether the organization raised funds through any of the following activities. Check all that apply.

a	Mail solicitations	e	Solicitation of non-government grants
b	Internet and email solicitations	f	Solicitation of government grants
c	Phone solicitations	g	Special fundraising events
d	In-person solicitations

Did the organization have a written or oral agreement with any individual (including officers, directors, trustees

or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?

YesNo

If "Yes," list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization.

(i) Name and address of individual or entity (fundraiser)		(ii) Activity	(iii) Did fundraiser have custody or control of contributions?		(iv) Gross receipts from activity	(v) Amount paid to (or retained by) fundraiser listed in col. (i)	(vi) Amount paid to (or retained by) organization
			Yes	No
	aab productions INC	events production		No	20,306,722	550,543	19,756,179
	Josh Woods Production	events production		No	3,941,393	361,400	3,579,993
	EIDOLON COMM INC	direct mail		No	850,329	192,503	657,827
	Sanky Comm Inc	direct mail		No	158,254	135,463	22,791






Total . . . . . . . . . . . . . . . . . . . .					25,256,698	1,239,909	24,016,790

List all states in which the organization is registered or licensed to solicit contributions or has been notified it is exempt from registration or licensing.

AL, AK, AR, CA, CO, CT, DC, FL, GA, HI, IL, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WV, WI

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 50083H

Schedule G (Form 990 or 990-EZ) 2018

Page 2

Part II

Fundraising Events. Complete if the organization answered "Yes" on Form 990, Part IV, line 18, or reported more than $15,000 of fundraising event contributions and gross income on Form 990-EZ, lines 1 and 6b. List events with gross receipts greater than $5,000.

		(a) Event #1 Cannes (event type)	(b) Event #2 Dallas (event type)	(c) Other events 18 (total number)	(d) Total events (add col. (a) through col. (c))
1	Gross receipts . . . . .	13,695,811	5,526,933	10,467,896	29,690,640
2	Less: Contributions . . . .	13,244,311	5,324,413	9,327,746	27,896,470
3	Gross income (line 1 minus line 2) . . . . . .	451,500	202,520	1,140,150	1,794,170

4	Cash prizes . . . . .
5	Noncash prizes . . . .
6	Rent/facility costs . . . .	1,071,064	257,624	442,774	1,771,462
7	Food and beverages . . .	382,908	226,613	730,059	1,339,580
8	Entertainment . . . .	1,832,283	248,752	1,559,893	3,640,928
9	Other direct expenses . . .	3,657,242	801,539	1,845,638	6,304,419
10	Direct expense summary. Add lines 4 through 9 in column (d) . . . . . . . . . .				13,056,389
11	Net income summary. Subtract line 10 from line 3, column (d). . . . . . . . . .				-11,262,219

Part III

Gaming. Complete if the organization answered "Yes" on Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.

		(a) Bingo	(b) Pull tabs/Instant bingo/progressive bingo	(c) Other gaming	(d) Total gaming (add col.(a) through col.(c))
1	Gross revenue . . . . .

2	Cash prizes . . . . .
3	Noncash prizes . . . .
4	Rent/facility costs . . . .
5	Other direct expenses . . .

Volunteer labor . . . .

	Yes %
	No

	Yes %
	No

	Yes %
	No

Direct expense summary. Add lines 2 through 5 in column (d) . . . . . . . . . . right arrow

Net gaming income summary. Subtract line 7 from line 1, column (d). . . . . . . . . right arrow

Enter the state(s) in which the organization conducts gaming activities:

Is the organization licensed to conduct gaming activities in each of these states? . . . . . . . .

YesNo

If "No," explain:

10a

Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? . . .

YesNo

If "Yes," explain:

Schedule G (Form 990 or 990-EZ) 2018

Page 3

Does the organization conduct gaming activities with nonmembers? . . . . . . . . . . .

YesNo

Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity

formed to administer charitable gaming? . . . . . . . . . . . . . . . . .

YesNo

Indicate the percentage of gaming activity conducted in:

The organization's facility . . . . . . . . . . . . . . . . . .

13a

An outside facility . . . . . . . . . . . . . . . . . . . .

13b

Enter the name and address of the person who prepares the organization's gaming/special events books and records:

Name

Address

15a

Does the organization have a contract with a third party from whom the organization receives gaming

revenue? . . . . . . . . . . . . . . . . . . . . . . . .

YesNo

If "Yes," enter the amount of gaming revenue received by the organization right arrow

$ and the

amount of gaming revenue retained by the third party right arrow

$ .

If "Yes," enter name and address of the third party:

Name

Address

Gaming manager information:

Name

Gaming manager compensation right arrow

Description of services provided right arrow

Director/officer Employee Independent contractor

Mandatory distributions:

Is the organization required under state law to make charitable distributions from the gaming proceeds to

retain the state gaming license? . . . . . . . . . . . . . . . . . . .

YesNo

Enter the amount of distributions required under state law distributed to other exempt organizations or spent

in the organization's own exempt activities during the tax year right arrow

Part IV

Supplemental Information. Provide the explanations required by Part I, line 2b, columns (iii) and (v); and Part III, lines 9, 9b, 10b, 15b, 15c, 16, and 17b, as applicable. Also provide any additional information. See instructions.

Return Reference

Explanation

SCHEDULE G, PART I

THE FOUNDATION FOR AIDS RESEARCH ACTUALLY PAID OUT $747,847 IN FUNDRAISING EXPENSES FOR THE YEAR ENDING SEPTEMBER 30, 2019. THIS AMOUNT IS REPORTED ON PART IX, LINE 11(E). FOR PURPOSES OF SCHEDULE G, THE FOUNDATION IS REPORTING ALL AMOUNTS PAID TO THE CONSULTANTS LISTED ON PART I, REGARDLESS OF WHETHER SUCH AMOUNTS WERE PURE FUNDRAISING EXPENSES OR EVENT PRODUCTION COSTS. ON SCHEDULE G, THE TOTAL AMOUNT PAID TO THE ORGANIZATIONS LISTED IS $1,239,909. OF THAT $1,239,909, ONLY $747,847 WAS PAID FOR FUNDRAISING SERVICES, THE REMAINING $492,062 WAS PAID FOR EVENT PRODUCTION SERVICES. IN THE INTERESTS OF CLARITY, THE FOUNDATION WOULD ALSO LIKE TO MAKE CLEAR THAT THE COMPENSATION REPORTED AS HAVING BEEN PAID TO THE PROFESSIONAL FUNDRAISERS REPORTED ON SCHEDULE G IS REPORTED ON A FISCAL YEAR BASIS. SOME OF THOSE SAME FUNDRAISERS ARE REPORTED ON THE FOUNDATION'S TOP 5 HIGHEST PAID INDEPENDENT CONTRACTORS LIST (IN SCHEDULE O). IN COMPLIANCE WITH THE INSTRUCTIONS TO THE FORM 990, COMPENSATION REPORTED FOR PART VII (AND LISTED IN SCHEDULE O) IS REPORTED ON A CALENDAR YEAR BASIS. ACCORDINGLY, AMOUNTS ON PART VII AND SCHEDULE G WILL NOT RECONCILE.

Schedule G (Form 990 or 990-EZ) 2018

Additional Data

Software ID:
Software Version:

- TIN:

Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990.
lBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

Name of the organization
THE FOUNDATION FOR AIDS RESEARCH

Employer identification number
13-3163817

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient

that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC section (if applicable)	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) The Rockefeller University 1230 York Avenue New York,NY10065	13-1624158	501(c)(3)	13,394	BASIC RESEARCH
(2) Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston,MA02215	04-2103881	501(c)(3)	213,426	BASIC RESEARCH
(3) Regents of the University of CA San Francisco 3333 California St San Francisco,CA94143	94-6036493	501(c)(3)	374,968	BASIC RESEARCH
(4) Foundation for the National Inst of Health 9650 Rockville Pike Bethesda,MD208143999	52-1986675	501(c)(3)	13,334	BASIC RESEARCH
(5) Mayo Clinic College of Medicine 200 First Street SW Rochester,MN55905	41-6011702	501(c)(3)	42,858	BASIC RESEARCH
(6) Oregon Health and Science University 3181 SW Sam Jackson Park Portland,OR97239	93-1176109	501(c)(3)	42,848	BASIC RESEARCH
(7) Boston University School of Medicine 650 Albany St EBRC 640 Boston,MA02118	04-3314093	501(c)(3)	75,001	BASIC RESEARCH
(8) Fred Hutchinson Cancer Research Center 1100 Fairview Ave N Seattle,WA98109	23-7156071	501(c)(3)	68,615	BASIC RESEARCH
(9) University of Maryland at Baltimore 725 Lombard St S615 Baltimore,MD21201	52-6002033	501(c)(3)	60,001	BASIC RESEARCH
(10) Fred Hutchinson Cancer Research Center 1100 Fairview Ave N Seattle,WA98109	23-7156071	501(c)(3)	42,858	BASIC RESEARCH
(11) International AIDS Vaccine Initiative 125 Broad St 9th Fl New York,NY10004	13-3870223	501(c)(3)	74,759	BASIC RESEARCH
(12) Weill Medical College of Cornell University 1300 York Avenue New York,NY10065	13-1623978	501(c)(3)	145,534	BASIC RESEARCH
(13) The Scripps Research Institute 130 Scripps Way La Jolla,CA33458	33-0435954	501(c)(3)	75,000	BASIC RESEARCH
(14) Emory University 1599 Clifton Rd Atlanta,GA303224250	58-0566256	501(c)(3)	75,000	BASIC RESEARCH
(15) State University of New York at Buffalo 520 Le Entrance Ste 211 Amherst,NY14228	91-6001537	501(c)(3)	16,666	BASIC RESEARCH
(16) Northwestern University Searle 6-512 320 E Chicago,IL60611	36-2167817	501(c)(3)	76,416	BASIC RESEARCH
(17) The Wistar Institute 3601 Spruce Street Philadelphia,PA19104	23-6434390	501(c)(3)	65,002	BASIC RESEARCH
(18) The Brigham and Women's Hospital Inc 75 Francis Street Boston,MA02115	04-2312909	501(c)(3)	50,002	BASIC RESEARCH
(19) Harvard Pilgrim Health Care Institute 93 WORCESTER St STE 100 Wellesley,MA02481	04-2452600	501(c)(3)	66,540	BASIC RESEARCH
(20) National Institutes of Health 40 Convent Drive Bethesda,MD20892		115	75,000	BASIC RESEARCH
(21) Johns Hopkins University 733 N BRDWY MRB 117 Baltimore,MD21205	52-0595110	501(c)(3)	102,261	GMT INITIATIVE
(22) Black AIDS Institute 1833 West Eigth 200 Los Angeles,CA90057	95-4742741	501(c)(3)	25,000	PREVENTION SCIENCE OUTREACH
(23) Schwab Charitable Fund PO Box 628298 Orlando,FL328628298	31-1640316	501(c)(3)	45,000	PREVENTION SCIENCE OUTREACH
(24) Health GAP (Global Access Project) 81 Prospect StREET Brooklyn,NY11201	20-5053765	501(c)(3)	47,995	PUBLIC POLICY
(25) University of California San Francisco 3333 California St San Francisco,CA94143	94-6036493	501(c)(3)	3,219,544	RESEARCH
(26) Harvard University 29 Oxford Street Cambridge,MA02138	04-2103580	501(c)(3)	130,106	RESEARCH
(27) Regents of the University of Minnesota 200 Oak Street Minneapolis,MN554552070	41-6007513	501(c)(3)	110,096	RESEARCH
(28) University of Washington 4333 Brooklyn Ave Seattle,WA981959472	91-6001537	501(c)(3)	283,681	RESEARCH
(29) Johns Hopkins University 733 N BRDWY MRB 117 Baltimore,MD21205	52-0595110	501(c)(3)	333,487	RESEARCH
(30) Trustees of the University of Pa 3451 Walnut St Philadelphia,PA191046250	23-1352685	501(c)(3)	311,171	RESEARCH
(31) Johns Hopkins University 733 N BRDWY MRB 117 Baltimore,MD21205	52-0595110	501(c)(3)	192,460	RESEARCH
(32) The Brigham and Women's Hospital Inc 75 Francis Street Boston,MA02115	04-2312909	501(c)(3)	50,597	RESEARCH
(33) Johns Hopkins University 733 N BRDWY MRB 117 Baltimore,MD21205	52-0595110	501(c)(3)	178,167	TREAT ASIA
(34) Massachusetts General Hospital 101 Huntington Ave 300 Boston,MA02199	04-2697983	501(c)(3)	30,000	TREAT ASIA

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2018

Page 2

Part III

Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance	(b) Number of recipients	(c) Amount of cash grant	(d) Amount of noncash assistance	(e) Method of valuation (book, FMV, appraisal, other)	(f) Description of noncash assistance

(1)
(2)
(3)
(4)
(5)
(6)
(7)

Part IV

Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.

Return Reference

Explanation

GRANTS AND ASSISTANCE

PART I, LINE 2 AMFAR PROVIDES GRANTS AND FELLOWSHIPS TO INDEPENDENT NOT-FOR-PROFIT ORGANIZATIONS THROUGH A PEER-REVIEW PROCESS. GRANT APPLICATIONS ARE FIRST REVIEWED BY THE FOUNDATION'S VOLUNTEER SCIENTIFIC ADVISORY COMMITTEE, WHICH COMPRISES RECOGNIZED EXPERTS IN THE MEDICAL, SCIENTIFIC, AND SOCIAL SCIENCES DISCIPLINES RELEVANT TO HIV AND AIDS. THE SCIENTIFIC ADVISORY COMMITTEE THEN SENDS ITS EVALUATIONS TO ONE OF THE THREE COMMITTEES (RESEARCH, GLOBAL INITIATIVES OR PUBLIC POLICY) OF THE FOUNDATION'S PROGRAM BOARD, WHICH SERVES IN AN ADVISORY CAPACITY TO THE BOARD OF TRUSTEES. AFTER A PROGRAM COMMITTEE HAS COMPLETED ITS REVIEW OF THE APPLICATIONS, IT PRESENTS ITS FUNDING RECOMMENDATIONS TO AMFAR'S EXECUTIVE COMMITTEE AND/OR THE FULL BOARD OF TRUSTEES FOR FINAL APPROVAL AND FUNDING AUTHORIZATION. GRANTS AND FELLOWSHIPS ARE PAYABLE OVER A ONE-TO-THREE-YEAR PERIOD, AND ARE REVOCABLE AT AMFAR'S OPTION IF THE RECIPIENT'S PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE TERMS OF THE GRANT OR FELLOWSHIPS. IN CERTAIN CASES, THE ACTUAL AMOUNTS PAID UNDER GRANTS AND FELLOWSHIP AWARDS MAY BE LESS THAN THE ORIGINAL AWARD IF THE RECIPIENT DOES NOT USE THE FULL AMOUNT AWARDED. THEREFORE, A RESERVE FOR UNEXPENDED GRANTS AND FELLOWSHIPS HAS BEEN RECORDED. SUBAWARDS ARE GRANTS AWARDED TO NOT-FOR-PROFIT ORGANIZATIONS TO SUPPORT THE COSTS OF COLLABORATION AND PARTICIPATION IN HIV/AIDS-RELATED RESEARCH PROJECTS FOR WHICH AMFAR HAS SECURED RESTRICTED FUNDS. SUBAWARDS ARE PAYABLE OVER A ONE-YEAR PERIOD, ALTHOUGH ADVANCE PAYMENTS, IN FULL OR IN PART, MAY BE ISSUED FOLLOWING EXECUTION OF THE SUBAWARD AGREEMENT. SUBAWARDS ARE CONTINGENT UPON THE AVAILABILITY OF FUNDS AND ARE REVOCABLE IF THE RECIPIENTS' PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE SUBAWARD TERMS.

Schedule I (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet

Attach to Form 990.
SchJMediumBullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? .............

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Yes

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ....................

Any related organization? .......................

If "Yes," on line 5a or 5b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ..................

Any related organization? ......................

If "Yes," on line 6a or 6b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................

If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2018

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column (B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1Kevin Frost Chief Executive Officer	(i) (ii)	424,771 ------------- 0	0 ------------- 0	55,637 ------------- 0	37,750 ------------- 0	59,271 ------------- 0	577,429 ------------- 0	0 ------------- 0
2Bradley Jensen Assistant Treasurer, CFO	(i) (ii)	268,290 ------------- 0	0 ------------- 0	0 ------------- 0	19,104 ------------- 0	43,063 ------------- 0	330,457 ------------- 0	0 ------------- 0
3Rowena Johnston ASST SEC, VP, RESEARCH	(i) (ii)	207,188 ------------- 0	0 ------------- 0	0 ------------- 0	14,564 ------------- 0	18,145 ------------- 0	239,897 ------------- 0	0 ------------- 0
4Edward Donnelly Asst Treasurer, Controller	(i) (ii)	165,914 ------------- 0	0 ------------- 0	0 ------------- 0	16,384 ------------- 0	16,623 ------------- 0	198,921 ------------- 0	0 ------------- 0
5Eric Muscatell Vice President of Development	(i) (ii)	219,278 ------------- 0	0 ------------- 0	0 ------------- 0	16,384 ------------- 0	18,145 ------------- 0	253,807 ------------- 0	0 ------------- 0
6Annette Sohn Vice President, TREAT Asia PGM	(i) (ii)	235,284 ------------- 0	0 ------------- 0	0 ------------- 0	17,391 ------------- 0	7,740 ------------- 0	260,415 ------------- 0	0 ------------- 0
7AnnMarie Shannahan Vice President, Public Info.	(i) (ii)	237,680 ------------- 0	0 ------------- 0	0 ------------- 0	16,803 ------------- 0	28,735 ------------- 0	283,218 ------------- 0	0 ------------- 0
8Gregorio Millet Vice President, Public Policy	(i) (ii)	186,211 ------------- 0	0 ------------- 0	0 ------------- 0	14,109 ------------- 0	41,963 ------------- 0	242,283 ------------- 0	0 ------------- 0
9Andrew McInness Director, Publications	(i) (ii)	170,102 ------------- 0	0 ------------- 0	0 ------------- 0	12,256 ------------- 0	55,728 ------------- 0	238,086 ------------- 0	0 ------------- 0
10Anthony Ancona Vice President, Human Resource	(i) (ii)	192,931 ------------- 0	0 ------------- 0	0 ------------- 0	13,571 ------------- 0	18,145 ------------- 0	224,647 ------------- 0	0 ------------- 0
11Susan Doster Chief Technology Officer	(i) (ii)	149,888 ------------- 0	0 ------------- 0	0 ------------- 0	11,132 ------------- 0	40,898 ------------- 0	201,918 ------------- 0	0 ------------- 0
12JONATHAN KEY DIRECTOR, PHILANTHROPY	(i) (ii)	193,887 ------------- 0	0 ------------- 0	0 ------------- 0	14,040 ------------- 0	43,063 ------------- 0	250,990 ------------- 0	0 ------------- 0
13Sebastian Gheith Associate Counsel	(i) (ii)	169,030 ------------- 0	0 ------------- 0	0 ------------- 0	12,250 ------------- 0	55,728 ------------- 0	237,008 ------------- 0	0 ------------- 0

Schedule J (Form 990) 2018

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.

Return Reference

Explanation

COMPENSATION

PART I, LINE 4 CHIEF EXECUTIVE OFFICER, KEVIN FROST, PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. IN CALENDAR YEAR 2018, AMFAR CONTRIBUTED $55,637 INTO MR. FROST'S NON-QUALIFIED RETIREMENT PLAN. THIS AMOUNT IS NOT REPORTED IN SCHEDULE J, PART II, COLUMN (C) BECAUSE THE CONTRIBUTED AMOUNT WAS DISTRIBUTED TO MR. FROST WITHIN THE SAME CALENDAR YEAR. INCLUDED IN SCHEDULE J COLUMN (B)(III) IS MR. FROST'S 2018 EMPLOYER-FUNDED 457(F) CONTRIBUTION OF $55,637.

Schedule J (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE M
(Form 990)

Department of the Treasury

Internal Revenue Service

Noncash Contributions

Complete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image

Attach to Form 990.
Right pointing arrow large image

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Part I

Types of Property

	(a) Check if applicable	(b) Number of contributions or items contributed	(c) Noncash contribution amounts reported on Form 990, Part VIII, line 1g	(d) Method of determining noncash contribution amounts
1 Art—Works of art ....
2 Art—Historical treasures .
3 Art—Fractional interests ..
4 Books and publications ..
5 Clothing and household goods .......
6 Cars and other vehicles ..
7 Boats and planes ....
8 Intellectual property ...
9 Securities—Publicly traded .	X	6	63,158	sales price
10 Securities—Closely held stock .
11 Securities—Partnership, LLC, or trust interests ....
12 Securities—Miscellaneous ..
13 Qualified conservation contribution—Historic structures .....
14 Qualified conservation contribution—Other ...
15 Real estate—Residential .
16 Real estate—Commercial ..
17 Real estate—Other ...
18 Collectibles .....
19 Food inventory ...
20 Drugs and medical supplies .
21 Taxidermy ......
22 Historical artifacts ....
23 Scientific specimens ..
24 Archeological artifacts ...
25 Other ( )
26 Other ( )
27 Other ( )
28 Other ( )

Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement

Yes

30a

During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which is not required to be used for exempt purposes for the entire holding period? ...................

30a

If "Yes," describe the arrangement in Part II.

Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?

Yes

32a

Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash

contributions? ..........................

32a

If "Yes," describe in Part II.

If the organization did not report an amount in column (c) for a type of property for which column (a) is checked,

describe in Part II.

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 51227J

Schedule M (Form 990) (2018)

Page 2

Part II

Supplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.

Return Reference	Explanation
FORM 990, SCHEDULE M, LINE 31	TO THE EXTENT THAT AMFAR RECEIVES NON-STANDARD CONTRIBUTIONS, THE ORGANIZATION'S POLICY IS TO LIQUIDATE THOSE ITEMS INTO CASH FOR EVENTUAL USE IN SUPPORT OF THE ORGANIZATION'S MISSION.

Schedule M (Form 990) (2018)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

Name of the organization

THE FOUNDATION FOR AIDS RESEARCH

Employer identification number

13-3163817

Return Reference	Explanation
PROGRAM SERVICE ACCOMPLISHMENTS (1)	LINE 4A: RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. AMFAR FELLOWSHIPS ALLOW TALENTED YOUNG RESEARCHERS TO CONDUCT ORIGINAL INVESTIGATIONS UNDER THE GUIDANCE OF EXPERIENCED SCIENTISTS, HELPING TO ENSURE THE LONG-TERM VITALITY OF AIDS RESEARCH. NEW GRANTS AND FELLOWSHIPS GRANTS AND FELLOWSHIPS ARE AWARDED THROUGH A RIGOROUS PROCESS OF PEER REVIEW BY A TEAM OF INDEPENDENT HIV/AIDS EXPERTS DRAWN LARGELY FROM THE VOLUNTEER SCIENTISTS ON AMFARS SCIENTIFIC ADVISORY COMMITTEE. GUIDED BY ITS SCIENTIFIC ADVISORS AND WITH THE APPROVAL OF ITS BOARD OF TRUSTEES, AMFAR PURSUES A STRATEGIC RESEARCH PLAN THAT FOCUSES ON THE PURSUIT OF A CURE FOR HIV. COUNTDOWN TO A CURE FOR AIDS IN 2015, AMFAR ANNOUNCED AN INVESTMENT STRATEGY OF UP TO $100 MILLION TO SUPPORT ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE, WHICH IS AIMED AT DEVELOPING THE SCIENTIFIC BASIS FOR A CURE BY THE END OF 2020. THE STRATEGY REPRESENTS AN UNPRECEDENTED EXPANSION OF AMFARS GRANT MAKING AND IS DESIGNED TO PROVIDE SUPPORT TO ANY SCIENTIST OR TEAM OF INVESTIGATORS FOR ANY RESEARCH IDEA WITH THE POTENTIAL TO ADVANCE THE SEARCH FOR A CURE, AT ANY STAGE OF ITS DEVELOPMENT. IT IS STRUCTURED TO PROVIDE SUSTAINED SUPPORT FOR A WIDE RANGE OF STUDIES THAT ADVANCE BOTH EMERGING AND ESTABLISHED IDEAS. THE STRATEGY COMPRISES THE FOLLOWING COMPONENTS: - AMFAR INSTITUTE FOR HIV CURE RESEARCH ESTABLISHED IN 2015 WITH A $20 MILLION GRANT OVER FIVE YEARS TO THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE INSTITUTE IS THE CORNERSTONE OF AMFARS CURE RESEARCH. - INNOVATION GRANTS THESE TWO-YEAR AWARDS OF UP TO $200,000 EACH ENABLE RESEARCHERS TO TEST INNOVATIVE IDEAS SUPPORTED BY LIMITED PRELIMINARY DATA. - IMPACT GRANTS THESE GRANTS OF UP TO $2 MILLION EACH OVER FOUR YEARS SUPPORT THE IN-DEPTH DEVELOPMENT OF CONCEPTS ALREADY UNDERPINNED BY PRELIMINARY DATA SHOWING GENUINE POTENTIAL FOR ACHIEVING A CURE. - INVESTMENT GRANTS AIMED AT RECRUITING THE EXPERIENCE AND EXPERTISE OF SCIENTISTS FROM OUTSIDE THE FIELD OF HIV, THESE $1 MILLION GRANTS ARE AWARDED OVER A FOUR-YEAR PERIOD. GRANTEES MAY HAVE EXPERTISE IN FIELDS SUCH AS CANCER, NEUROSCIENCE, OR INFLAMMATORY DISEASE THAT CAN DIRECTLY INFORM EFFORTS TO CURE HIV. - ARCHE LAUNCHED IN 2010, THE AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION, OR ARCHE, SUPPORTS COLLABORATIVE TEAMS OF SCIENTISTS IN THE U.S. AND AROUND THE WORLD WORKING ON A RANGE OF HIV CURE STRATEGIES. - OPPORTUNITY FUND THIS FUNDING MECHANISM ENABLES AMFAR TO RESPOND QUICKLY TO EMERGING AND UNFORESEEN RESEARCH OPPORTUNITIES. SINCE LAUNCHING THE COUNTDOWN TO A CURE FOR AIDS INITIATIVE, AMFAR HAS AWARDED 79 COUNTDOWN GRANTS TOTALING MORE THAN $48 MILLION TO SUPPORT RESEARCH CONDUCTED BY 277 SCIENTISTS WORKING AT 95 INSTITUTIONS IN 15 COUNTRIES. IMPACT GRANTS IN SEPTEMBER 2018, AMFAR AWARDED GRANTS TOTALING $828,000 TO ADVANCE TWO CRITICAL AREAS OF HIV CURE RESEARCH. FIVE GRANTS ARE SUPPORTING A RANGE OF EFFORTS TO UNDERSTAND THE MECHANISMS AND PREDICTORS OF POST-TREATMENT CONTROL, WHEREBY A SMALL NUMBER OF INDIVIDUALS ARE ABLE TO CONTROL THEIR HIV AFTER STOPPING TREATMENT. THREE ADDITIONAL GRANTEES ARE STUDYING HIV-POSITIVE POPULATIONS IN LOW- AND MIDDLE-INCOME COUNTRIES TO LOOK FOR DIFFERENCES IN HOW THE PERSISTENT VIRAL RESERVOIR-THE PRINCIPAL BARRIER TO A CUR-FORMS AND CHANGES OVER TIME. IN A COHORT OF POST-TREATMENT CONTROLLERS FROM ONE OF THE LARGEST HIV CLINICAL TRIAL NETWORKS IN THE WORLD, DR. JONATHAN LI OF BRIGHAM AND WOMEN'S HOSPITAL IN BOSTON IS USING NEXT-GENERATION GENOMIC SEQUENCING TO INVESTIGATE WHETHER CHARACTERISTICS OF THE VIRUS OR IMMUNOLOGIC RESPONSES CAN PREDICT POST-TREATMENT CONTROL. ANOTHER GRANTEE, DR. GODWIN NCHINDA, A RESEARCHER IN YAOUNDE, CAMEROON, HAS IDENTIFIED A COHORT OF WOMEN WHO RECEIVED ANTIRETROVIRAL THERAPY (ART) DURING PREGNANCY AND CONTINUE TO CONTROL THEIR VIRUS DESPITE DISCONTINUING TREATMENT AFTER GIVING BIRTH. HE IS STUDYING THIS GROUP TO DETERMINE THE CAUSES OF THEIR VIRAL CONTROL. THE MAJORITY OF WHAT IS KNOWN ABOUT HIV COMES FROM RESEARCH DONE IN HIGH-INCOME COUNTRIES, WHERE HIV SUBTYPE B PREDOMINATES. HOWEVER, SUBTYPE B ACCOUNTS FOR JUST 12% OF GLOBAL HIV INFECTIONS. DR. EDWARD KANKAKA OF THE RAKAI HEALTH SCIENCES PROGRAM IN KAMPALA, UGANDA, HAS SHOWN THAT NON-B HIV-POSITIVE UGANDANS HAD A SMALLER RESERVOIR OF PERSISTENT VIRUS COMPARED TO PEOPLE INFECTED WITH SUBTYPE B. DR. KANKAKA IS EXPANDING THESE STUDIES TO DETERMINE WHETHER FORMATION AND MAINTENANCE OF THE RESERVOIR DIFFER IN THESE POPULATIONS. IN DURBAN, SOUTH AFRICA, DR. ALEX SIGAL IS EXAMINING THE INFLUENCE OF TUBERCULOSIS-A COMMON CO-INFECTION IN LOW- AND MIDDLE-INCOME COUNTRIES-ON THE HIV RESERVOIR. HE IS EXPLORING WHETHER THE IMMUNE RESPONSE TO TB ITSELF ALTERS HIV REACTIVATION-A KEY COMPONENT OF THE "SHOCK AND KILL" APPROACH TO CURING HIV. THE REMAINING GRANTEES ARE DR. MOHAMED ABDEL-MOHSEN OF THE WISTAR INSTITUTE, PHILADELPHIA, PA; DR. JOHN FRATER OF OXFORD UNIVERSITY, UK; DR. REENA RAJASURIAR OF THE UNIVERSITY OF MALAYA, KUALA LUMPUR, MALAYSIA; AND DR. RUI WANG OF HARVARD PILGRIM HEALTHCARE INSTITUTE, WELLESLEY, MA. INVESTMENT GRANTS IN FEBRUARY 2019, AMFAR ANNOUNCED NEW FUNDING TO RESEARCHERS USING CUTTING-EDGE TECHNOLOGY TO ADDRESS THE MAIN BARRIER TO AN HIV CURE: THE PERSISTENT RESERVOIRS OF VIRUS NOT CLEARED BY ART. TOTALING $800,000, THIS NEW ROUND OF INVESTMENT GRANTS LAUNCHED THE CRITICAL THIRD PHASE OF A RESEARCH PROJECTS BEGUN IN 2017. IN THE FIRST TWO PHASES OF HER STUDY, DR. HUI ZHANG OF JOHNS HOPKINS UNIVERSITY USED MASS SPECTROMETRY TO SCAN THE SURFACE OF HUMAN CELLS FOR PROTEINS-BIOMARKERS-THAT DISCRIMINATE BETWEEN LATENTLY INFECTED AND UNINFECTED CELLS. AFTER SCANNING A VARIETY OF CELL LINES, SHE IDENTIFIED 17 POTENTIAL TARGETS. IN PHASE THREE, DR. ZHANG IS TEAMING UP WITH HIV SCIENTIST DR. WEIMING YANG, ALSO OF JOHNS HOPKINS UNIVERSITY, TO DETERMINE IN A PRECLINICAL STUDY WHETHER SPECIFICALLY KILLING CELLS DISPLAYING ANY OF THESE 17 PROTEINS WILL ELIMINATE THE LATENT RESERVOIR. ARCHE (AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION) IN SEPTEMBER 2018, AMFAR AWARDED $800,000 IN NEW FUNDING TO SIX TEAMS OF RESEARCHERS DEVELOPING AN AMBITIOUS GENE THERAPY-BASED APPROACH TO CURING HIV. THE AWARD LAUNCHED A CRITICAL NEW PHASE IN A STUDY INITIATED IN 2017. IN A THREE-PRONGED ATTACK ON THE HIV RESERVOIR, THE RESEARCHERS ARE EMPLOYING BROADLY NEUTRALIZING ANTIBODIES, CAR STEM CELLS-CELLS GENETICALLY REPROGRAMMED TO RECOGNIZE AND ATTACK INFECTED CELLS-AND MOLECULAR SCISSORS TARGETING THE VIRUS. THE GRANT WAS SUPPORTED IN PART BY THE BILL AND MELINDA GATES FOUNDATION. THE INVESTIGATORS ARE: DR. HILDEGARD BNING OF HANNOVER MEDICAL SCHOOL, GERMANY; DR. KEITH JEROME OF THE UNIVERSITY OF WASHINGTON, SEATTLE; DR. HANS-PETER KIEM OF FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE; DR. SCOTT KITCHEN OF UCLA; DR. YASUHIRO TAKEUCHI OF UNIVERSITY COLLEGE LONDON; DR. DREW WEISSMAN OF UNIVERSITY OF PENNSYLVANIA IN PHILADELPHIA; AND DR. RICHARD WYATT OF THE SCRIPPS RESEARCH INSTITUTE IN LA JOLLA, CA. IN JUNE 2019, AMFAR AWARDED $1.16 MILLION IN ARCHE GRANTS FOR A PAIR OF INNOVATIVE RESEARCH STUDIES PURSUING DIFFERENT ANGLES TO ATTACK HIV. DR. KEITH JEROME OF THE UNIVERSITY OF WASHINGTON, SEATTLE, WAS AWARDED $344,000 FOR A PROJECT THAT AIMS TO ADVANCE A GENE THERAPY STRATEGY FOR CURING HIV. GENE THERAPY IS VERY PROMISING, BUT IT CARRIES RISKS AND IT IS EXTREMELY EXPENSIVE. AMFARS ARCHE-GT CONSORTIUM PLANS TO REDUCE COSTS BY DEVELOPING IN VIVO GENE THERAPY IN WHICH THE GENE-ENGINEERING TOOLS ARE INJECTED DIRECTLY INTO THE PATIENT USING VECTORS, WHICH FUNCTION AS "TROJAN HORSES". DR. JEROMES TEAM PLANS TO COMPARE WHICH OF 11 VECTORS DELIVERS THE GENE-EDITING TOOLS MOST EFFECTIVELY TO THE VARIOUS SPECIFIC TISSUES THAT ARE BEING TARGETED. THESE LEAD CANDIDATES WILL THEN BE USED IN FUTURE STUDIES OF COMBINATION IN VIVO GENE THERAPY INTERVENTIONS.
AND DR. JONATHAN LI OF BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, WAS	AWARDED $815,000 FOR A PROJECT STUDYING POST-TREATMENT CONTROL OF THE VIRUS (SEE IMPACT GRANTS ABOVE). DR. LI AND HIS TEAM HAVE ASSEMBLED AN IMPRESSIVE COHORT OF POST-TREATMENT CONTROLLERS-INDIVIDUALS WHO EXHIBIT THE RARE ABILITY TO CONTROL THE VIRUS AFTER STOPPING ART-FROM ONE OF THE LARGEST HIV CLINICAL TRIAL NETWORKS GLOBALLY. THE RESEARCH TEAM IS GATHERING AND ANALYZING SAMPLES FROM THIS MULTINATIONAL POST-TREATMENT CONTROL COHORT AND WILL BE ABLE TO EMPLOY CUTTING-EDGE TOOLS TO INVESTIGATE WHETHER CHARACTERISTICS OF THE VIRUS OR IMMUNOLOGIC RESPONSES CAN PREDICT POST-TREATMENT CONTROL. DISCOVERING WHAT LEADS TO POST-TREATMENT CONTROL IN SOME PEOPLE COULD HELP TO ACHIEVE DURABLE ART-FREE CONTROL IN ALL PEOPLE LIVING WITH HIV. MATHILDE KRIM FELLOWSHIPS IN SEPTEMBER 2018, AMFAR ANNOUNCED THE RECIPIENT OF THE 2018 MATHILDE KRIM FELLOWSHIP IN BASIC BIOMEDICAL RESEARCH: DR. YEN-TING LAI OF THE VACCINE RESEARCH CENTER/NATIONAL INSTITUTES OF HEALTH IN BETHESDA, MD. THE 2019 KRIM FELLOWS, DR. MAOLIN LU OF YALE UNIVERSITY IN NEW HAVEN, CT, AND DR. SHAHEED ABDULHAQQ, OF OREGON HEALTH AND SCIENCE UNIVERSITY IN PORTLAND, OR, WERE ANNOUNCED IN SEPTEMBER 2019. THE KRIM FELLOWSHIPS SUPPORT BRIGHT YOUNG SCIENTISTS ADVANCING INNOVATIVE SOLUTIONS TO HIV/AIDS. EACH FELLOW IS AWARDED APPROXIMATELY $150,000 OVER TWO YEARS. PROGRAM SERVICE ACCOMPLISHMENTS (1) CONT. PUBLISHED RESEARCH RESEARCH STUDIES MAKE THE GREATEST IMPACT ON THE HIV FIELD AND ON THE BROADER SCIENTIFIC COMMUNITY WHEN THEY ARE PUBLISHED IN SCIENTIFIC JOURNALS. IN FY2019, 53 SCIENTIFIC PUBLICATIONS RESULTED FROM AMFAR-FUNDED RESEARCH. EXAMPLES INCLUDE: THE "LONDON PATIENT" IS POTENTIALLY CURED FOLLOWING A STEM CELL TRANSPLANT THE "BERLIN PATIENT"-TIMOTHY BROWN-WAS THE FIRST PERSON KNOWN TO HAVE BEEN CURED OF HIV. DIAGNOSED WITH LEUKEMIA, HE RECEIVED A STEM CELL TRANSPLANT FROM A DONOR WITH A RARE GENETIC MUTATION CONFERRING RESISTANCE TO HIV INFECTION. AMFAR'S ICISTEM CONSORTIUM WAS ESTABLISHED TO REPLICATE AND IDENTIFY THE MECHANISMS UNDERLYING HIS CURE, AND HAS ASSEMBLED THE LARGEST COHORT OF PATIENTS WITH HIV WHO HAVE RECEIVED, OR WILL SOON RECEIVE, STEM CELL TRANSPLANTS. IN THE MARCH 2019 ISSUE OF NATURE, DR. RAVI GUPTA AND COLLEAGUES REPORTED ON THE "LONDON PATIENT," THE SECOND INDIVIDUAL POTENTIALLY CURED FOLLOWING A STEM CELL TRANSPLANT. THIS CASE-ALONG WITH THE "DSSELDORF PATIENT," A THIRD POTENTIALLY CURED INDIVIDUAL-IS PROVIDING CRITICAL NEW DATA TO COMPARE WITH THE "BERLIN PATIENT." THE ABILITY TO CONTROL HIV WITHOUT ANTIRETROVIRAL THERAPY RUNS IN FAMILIES CCR5, THE PRIMARY RECEPTOR ENABLING HIV TO INFECT CELLS, IS KNOWN FOR ITS ROLE IN THE CURE OF THE "BERLIN PATIENT" FOLLOWING A STEM CELL TRANSPLANT WITH DONOR CELLS BEARING A MUTATED CCR5 PROTEIN. IN THE APRIL 2019 ISSUE OF ELIFE, DR. STEVEN DEEKS AND COLLEAGUES FOUND ANOTHER WAY THAT CCR5 IS CONNECTED TO THE ABILITY TO CONTROL HIV WITHOUT ART. THE RESEARCHERS STUDIED 131 INDIVIDUALS-ABOUT HALF ELITE AND HALF VIREMIC CONTROLLERS, ABLE TO NATURALLY MAINTAIN VIRAL LOADS OF LESS THAN 50 OR 2000 COPIES, RESPECTIVELY-SOME OF WHOM HAVE BEEN INFECTED SINCE 1980. THEY DISCOVERED THAT CONTROL WAS RELATED TO A NATURAL AND PARTIAL RESISTANCE TO INFECTION IN CONTROLLERS AND NONCONTROLLERS. FURTHER ANALYSIS SHOWED THAT CONTROLLERS HAD LESS CCR5 PRESENT ON THEIR CELLS THAN NONCONTROLLERS, AND THEIR CELLS WERE LESS PERMISSIVE TO HIV INFECTION. FURTHERMORE, NATURAL RESISTANCE TO HIV WAS SHOWN TO BE INHERITED, AS MULTIPLE GENERATIONS OF FAMILY MEMBERS, MALE AND FEMALE, FROM ONE OF THE VIREMIC CONTROLLERS HAD A SIMILAR PROFILE OF LOWERED CCR5. STUDYING HOW AND UNDER WHAT CIRCUMSTANCES THESE CONTROLLERS MAKE LOWER LEVELS OF CCR5 MAY LEAD TO NEW DISCOVERIES THAT COULD INFORM INTERVENTIONS FOR A FUNCTIONAL CURE. IDENTIFYING A BIOMARKER FOR THE 'ACTIVE' HIV RESERVOIR IN THE MAY 2019 ISSUE OF PATHOGENS AND IMMUNITY, DRS. TIMOTHY HENRICH AND PETER HUNT, BOTH AT THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, REPORTED ON EFFORTS TO SEE WHETHER THE PROTEIN CD32-PREVIOUSLY SHOWN TO BE A BIOMARKER FOR HIV ACTIVITY IN BLOOD CELLS-MIGHT ALSO DENOTE ACTIVITY IN THE TISSUES. THE RESEARCHERS EXAMINED GUT BIOPSIES FROM FOUR STUDY PARTICIPANTS WHOSE MEDICATION HAD REDUCED THE HIV IN THEIR BLOOD TO UNDETECTABLE LEVELS. THEY NOTED THAT ABOUT FOUR IN EVERY 100,000 CELLS IN THE TISSUE HAD STARTED ACTIVITY OF THE PROVIRUS, MEANING THEY HAD BEGUN THE FIRST STEPS TOWARDS PRODUCING NEW VIRUSES. THE STUDY CONFIRMED THAT CD32 MAY NOT BE A BIOMARKER OF THE LATENT RESERVOIR, BUT MAY BE A BIOMARKER OF WHAT MIGHT BE CALLED THE "ACTIVE RESERVOIR"-PERSISTENT VIRUS THAT IS PROBABLY FIRST TO RE-SEED INFECTION WHEN ART IS STOPPED. THINKING ON THE NATURE OF THE RESERVOIR IS EVOLVING TO INCLUDE NOT ONLY LATENT, BUT ALSO ACTIVE RESERVOIR, AND BOTH ARE MAJOR BARRIERS TO A CURE. FINDING A WAY TO DIFFERENTIATE CELLS HARBORING ACTIVE RESERVOIR FROM HEALTHY, UNINFECTED CELLS WOULD BE AN IMPORTANT ADVANCE. HIV CURE SUMMIT IN DECEMBER 2018, AMFAR HELD ITS FIFTH ANNUAL HIV CURE SUMMIT AT THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (UCSF), WHERE THE AMFAR INSTITUTE FOR HIV CURE RESEARCH IS BASED. LEADING AMFAR-FUNDED CURE RESEARCHERS DETAILED THEIR PROGRESS AND DISCUSSED THE SCIENTIFIC CHALLENGES THAT CONTINUE TO STAND IN THE WAY OF A CURE. MUCH OF THE DISCUSSION CENTERED ON ANALYTIC TREATMENT INTERRUPTION. THE ONLY MEANS CURRENTLY AVAILABLE FOR PROVING THAT A PERSON HAS BEEN CURED IS TO REMOVE ANTIRETROVIRAL THERAPY UNDER CLOSELY CONTROLLED AND MONITORED CONDITIONS. DR. ROWENA JOHNSTON, AMFAR VICE PRESIDENT AND DIRECTOR OF RESEARCH, ELUCIDATED THE TWO TYPES OF CURE THAT RESEARCHERS ARE PURSUING: ERADICATION AND POST-TREATMENT CONTROL. IN ERADICATION, AN INDIVIDUAL COMPLETELY CLEARS HIV FROM HIS OR HER BODY; AND IN POST-TREATMENT CONTROL SOME VIRUS REMAINS, BUT THE IMMUNE SYSTEM CAN CONTROL IT WITHOUT ART. DR. STEVEN DEEKS, A PROFESSOR OF MEDICINE AT UCSF AND A LEAD INVESTIGATOR AT THE AMFAR INSTITUTE, EXPLAINED THE COMPLEX CLINICAL STUDY HE IS ABOUT TO EMBARK ON. IN THE STUDY, DR. DEEKS AND HIS TEAM WILL ADMINISTER A SERIES OF THERAPEUTIC VACCINES, BROADLY NEUTRALIZING ANTIBODIES, AND AN AGENT TO SHOCK THE VIRUS OUT OF ITS HIDING PLACES. THE SUMMIT ALSO FEATURED A RANGE OF PERSPECTIVES FROM MEMBERS OF THE COMMUNITY ADVISORY BOARD FOR THE AMFAR INSTITUTE AND OTHER COMMUNITY LEADERS. THINK TANKS CONSISTENT WITH AMFARS COMMITMENT TO INVESTIGATE EVERY AVENUE THAT MAY LEAD TO A CURE, THE FOUNDATION REGULARLY HOSTS THINK TANKS THAT BRING TOGETHER LEADING INVESTIGATORS IN VARIOUS FIELDS. IN MARCH 2019, AMFAR HOSTED A THINK TANK ON GENE THERAPY. EXPERTS GATHERED TO DISCUSS CUTTING-EDGE APPROACHES TO CURING HIV THAT AMFAR COULD PURSUE THROUGH ITS GENE THERAPY RESEARCH INITIATIVE, ARCHE-GT. IN MAY 2019, MEMBERS OF AMFARS ICISTEM CONSORTIUM OF EUROPEAN RESEARCHERS THAT AIMS TO REPLICATE THE CASE OF "THE BERLIN PATIENT" GATHERED FOR A THINK TANK IN DUBLIN, IRELAND. ICISTEM WAS CREATED AND IS FUNDED BY AMFAR THROUGH ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE. AND IN AUGUST 2019, AMFAR HOSTED A THINK TANK IN NEW YORK CITY ON THE CCR5 RECEPTOR AS A TARGET IN CURE RESEARCH. THE RESEARCHERS DISCUSSED WAYS TO USE CCR5 TO DEVELOP A MORE GENERALIZABLE CURE THAN ONE INVOLVING RISKY AND COSTLY STEM CELL TRANSPLANTS.
PROGRAM SERVICE ACCOMPLISHMENTS (2)	LINE 4B: TREAT ASIA: AMFARS TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF TREATMENTS FOR HIV AND ITS CO-INFECTIONS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. TREAT ASIA SCIENTISTS PRODUCED 38 PUBLICATIONS IN PEER-REVIEWED MEDICAL JOURNALS IN 2019. INTERNATIONAL AIDS DATABASE TREAT ASIA MANAGES THE ASIA-PACIFIC SECTION OF THE INTERNATIONAL EPIDEMIOLOGY DATABASES TO EVALUATE AIDS (IEDEA), A GLOBAL COLLABORATION ESTABLISHED BY THE U.S. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. IN FY2019, THE IEDEA CONSORTIUM COMPLETED STAY (STUDY OF TRANSITIONING ASIAN YOUTH), WHICH AIMS TO DOCUMENT THE EXPERIENCE OF HIV-POSITIVE YOUNG ADULTS WHO ARE TRANSITIONING FROM PEDIATRIC TO ADULT CARE. TREAT ASIA HIV OBSERVATIONAL DATABASE (TAHOD) TREAT ASIA PIONEERED THE REGIONS FIRST ADULT OBSERVATIONAL DATABASE FOR HIV/AIDS, WHICH NOW INCLUDES ANONYMOUS DATA FROM NEARLY 10,000 PATIENTS AT 21 CLINICAL SITES IN 12 COUNTRIES. THE INFORMATION GATHERED IN THE DATABASE INFORMS THE DEVELOPMENT OF MORE EFFECTIVE RESEARCH AND TREATMENT PROGRAMS AND HELPS DEFINE TREATMENT STANDARDS SPECIFIC TO HIV/AIDS IN ASIA. TAHOD LOW-INTENSITY TRANSFER LAUNCHED IN 2014, TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) CONTAINS DATA FROM OVER 37,000 HIV-POSITIVE PATIENTS ACROSS TEN TREAT ASIA NETWORK SITES. AS AN EXTENSION OF TAHOD, TAHOD-LITE AIMS TO INCREASE THE SCOPE OF ADULT DATA COLLECTION BY GATHERING A SUBSET OF CORE VARIABLES FROM THE ENTIRE COHORT OF HIV-INFECTED PATIENTS WHO HAVE SOUGHT CARE AT SELECTED TAHOD SITES. TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE THE TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) IS A REGIONAL PEDIATRIC HIV STUDY SET UP BY TREAT ASIA IN 2006. IT WAS MODELED AFTER THE ADULT DATABASE AND INCLUDES DATA FROM MORE THAN 6,400 CHILDREN AND ADOLESCENTS AT 17 CLINICAL SITES IN CAMBODIA, INDIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM. INTEGRATING HIV, MENTAL HEALTH, AND IMPLEMENTATION SCIENCE RESEARCH IN MAY 2019, THE U.S. NATIONAL INSTITUTES OF HEALTH AWARDED A FIVE-YEAR, $1.4 MILLION GRANT TO TREAT ASIA AND COLUMBIA UNIVERSITY TO ESTABLISH AN INNOVATIVE PLATFORM FOR INTEGRATING HIV, MENTAL HEALTH, AND IMPLEMENTATION SCIENCE RESEARCH IN THE ASIA-PACIFIC REGION. THE OBJECTIVE OF THE CHIMERA PROGRAM (CAPACITY DEVELOPMENT FOR HIV AND MENTAL HEALTH RESEARCH IN ASIA) IS TO ADDRESS THE DUAL AND INTERLINKED BURDENS OF HIV AND MENTAL HEALTH. CO-LED BY PRINCIPAL INVESTIGATORS DR. ANNETTE SOHN, AMFAR VICE PRESIDENT AND DIRECTOR OF TREAT ASIA, AND DR. MILTON WAINBERG, PROFESSOR OF CLINICAL PSYCHIATRY AT COLUMBIA UNIVERSITY AND THE NEW YORK STATE PSYCHIATRIC INSTITUTE, THE PROGRAM AIMS TO BUILD A TEAM WITHIN THE ASIA-PACIFIC WITH THE CAPACITY TO LEAD REGIONAL HIV-MENTAL HEALTH-IMPLEMENTATION SCIENCE RESEARCH THAT WILL INFORM PUBLIC HEALTH POLICY AND IMPROVE THE QUALITY OF CLINICAL CARE FOR PEOPLE LIVING WITH HIV. THE PROGRAM IS NESTED WITHIN THE IEDEA (SEE ABOVE) ASIA-PACIFIC REGIONAL RESEARCH NETWORK THAT TREAT ASIA DIRECTS. CHIMERA WILL CREATE THE OPPORTUNITY TO BRING TOGETHER STELLAR TRAINING FACULTY FROM ACADEMIC CENTERS AND PUBLIC HEALTH AND DEVELOPMENT AGENCIES WITHIN THE REGION AND ACROSS THE WORLD, AND WILL BUILD ON EXISTING NIH-FUNDED MENTAL HEALTH RESEARCH BEING CONDUCTED THROUGH IEDEA ASIA-PACIFIC. EMPOWERING YOUTH ADVOCATES IN DECEMBER 2018, TREAT ASIAS YOUTH ACATA-ASIA COMMUNITY FOR AIDS TREATMENT AND ADVOCACY-HELD A WORKSHOP IN BANGKOK. FOCUSED ON MODELS OF SERVICE DELIVERY FOR KEY POPULATIONS, THE WORKSHOP INCLUDED SITE VISITS TO COMMUNITY-BASED OR KEY POPULATION-FRIENDLY HIV SERVICE PROVIDERS IN BANGKOK. EXPANDING ACCESS TO HIV TREATMENT IN 2018, THE WORLD HEALTH ORGANIZATION (WHO) RECOMMENDED DOLUTEGRAVIR (DTG)-BASED REGIMENS AS THE PREFERRED FIRST-LINE HIV TREATMENT FOR ADULTS AND ADOLESCENTS. BUT IN THE ASIA-PACIFIC REGION, ACCESS TO DTG-BASED REGIMENS REMAINS SEVERELY LIMITED. TO ACCELERATE DTG SCALE-UP IN THE REGION, TREAT ASIA AND THE CLINTON HEALTH ACCESS INITIATIVE ORGANIZED A WORKSHOP IN BANGKOK IN MARCH 2019 TO HELP NETWORKS OF PEOPLE LIVING WITH HIV AND OTHER TREATMENT ACCESS ADVOCATES BETTER UNDERSTAND ISSUES AROUND DTG ACCESS AND USE, AND COORDINATE FUTURE ADVOCACY EFFORTS. ATTENDED BY 25 PARTICIPANTS FROM NINE ASIAN COUNTRIES, THE WORKSHOP BUILT UPON EARLIER COLLABORATIVE EFFORTS WITH THE WHO SOUTH EAST ASIA AND WESTERN PACIFIC REGIONAL OFFICES TO ENHANCE ACCESS TO NEWER HIV AND HEPATITIS C MEDICATIONS. IN APRIL 2019, GITEN KHWAIRAKPAM, TREAT ASIAS PROJECT MANAGER FOR COMMUNITY AND POLICY, LED A TRAINING IN BANGKOK FOR REGIONAL COMMUNITY ADVOCATES AROUND THE USE OF DTG. AND THE FOLLOWING MONTH, TREAT ASIA CO-ORGANIZED A WEBINAR WITH THE WHO WESTERN PACIFIC OFFICE AROUND THE USE OF DTG AND ACCESS ISSUES IN THE REGION. HELPING ADOLESCENTS TRANSITION TO ADULT CARE THERE ARE INCREASINGLY LARGE NUMBERS OF YOUNG ADULTS IN THE ASIA-PACIFIC REGION WITH RECENTLY ACQUIRED INFECTIONS. IN 2017, 30% OF NEW HIV INFECTIONS IN THE ASIA-PACIFIC OCCURRED IN PEOPLE AGED 15-24 YEARS. CONTINUING ITS COMMITMENT TO HELPING ADOLESCENTS TRANSITION TO ADULT CARE, IN JANUARY 2019 TREAT ASIA HELD A THINK TANK ON YOUNG ADULT COHORT RESEARCH TO EXPLORE OPPORTUNITIES FOR A NEW COHORT STUDY FOCUSING ON YOUNG ADULTS. ADVOCATING FOR CO-INFECTION TREATMENT ACCESS IN JUNE 2019, TREAT ASIA HELD ITS ANNUAL REGIONAL ADVOCACY MEETING ON HEPATITIS C, HIV, AND TUBERCULOSIS TREATMENT IN BANGKOK, WITH CIVIL SOCIETY ORGANIZATIONS, CLINICAL CARE PROFESSIONALS, AND INTELLECTUAL PROPERTY EXPERTS. DURING THE YEAR, TREAT ASIA ALSO ATTENDED AND PRESENTED AT SEVERAL CONFERENCES ON HEPATITIS C TREATMENT ACCESS AND PARTNERED WITH CIVIL SOCIETY GROUPS AND FUNDERS ON ADVOCACY EFFORTS. PUBLICATIONS TREAT ASIA DIRECTOR DR. ANNETTE SOHN CO-AUTHORED AN OP-ED FOR ASIA-PACIFIC BIOTECH NEWS, TITLED "ASIA-PACIFIC: FALLING BEHIND IN THE FIGHT AGAINST HIV/AIDS." THE OP-ED, COAUTHORED BY A SINGAPOREAN INVESTIGATOR, DISCUSSED THE CURRENT STATE OF THE HIV EPIDEMIC IN ASIA, AND HIGHLIGHTED PRIORITY ISSUES FOR THE REGIONAL RESPONSE. IN JANUARY 2019, TREAT ASIA PRODUCED THE FACT SHEET, WHO GUIDELINES FOR THE SCREENING, CARE, AND TREATMENT OF PERSONS WITH HEPATITIS C INFECTION. THE FACT SHEET SUMMARIZES WHO GUIDELINES (UPDATED, JULY 2018) ON CARE AND TREATMENT OF HEPATITIS C VIRUS INFECTION, WHICH ARE AIMED AT HELPING POLICYMAKERS AND HEALTHCARE PROVIDERS IN LOW- AND MIDDLE-INCOME COUNTRIES ESTABLISH SCREENING, CARE, AND TREATMENT PROGRAMS. AND IN FEBRUARY 2019, TREAT ASIA UPDATED THE BROCHURE, TREAT ASIA: A COOPERATIVE APPROACH TO COMBATING HIV IN ASIA AND THE PACIFIC, WHICH HIGHLIGHTS KEY FACTS AND FIGURES OF THE HIV EPIDEMIC IN THE REGION. THE BROCHURE MAKES THE CASE THAT TREAT ASIAS UNIQUE CAPACITY TO BRING TOGETHER RESEARCHERS, CLINICIANS, ADVOCATES, AND POLICYMAKERS PLAYS AN IMPORTANT ROLE IN THE REGIONS RESPONSE TO HIV/AIDS, AND HAS BECOME A MODEL FOR REGIONAL COLLABORATION. IN ADDITION, TREAT ASIA CONTINUED TO PUBLISH LAY-LANGUAGE ARTICLES ON HIV/AIDS RESEARCH, POLICY, AND COMMUNITY ISSUES FACING THE ASIA-PACIFIC AS A WHOLE. THE ARTICLES AND EDUCATIONAL PIECES APPEAR IN THE TREAT ASIA REPORT, A BIMONTHLY E-NEWSLETTER, AND ON TREAT ASIAS WEBSITE, WWW.TREATASIA.ORG. 18TH ANNUAL NETWORK MEETING THE 2018 TREAT ASIA ANNUAL NETWORK MEETING WAS HELD IN OCTOBER 2018 IN BANGKOK, THAILAND, WHERE MORE THAN 120 ADULT AND PEDIATRIC INVESTIGATORS, DONORS, AND PROGRAM PARTNERS GATHERED TO REVIEW PROGRESS ON THE NETWORKS RESEARCH AGENDA, HEAR ABOUT REGIONAL HIV-RELATED POLICY PRIORITIES, AND PLAN FOR FUTURE INITIATIVES. OTHER CONFERENCES TREAT ASIA STAFF AND NETWORK INVESTIGATORS ATTENDED AND PRESENTED AT SEVERAL REGIONAL AND INTERNATIONAL CONFERENCES ON HIV-RELATED ISSUES. EXAMPLES INCLUDE: IAS 2019 TREAT ASIA HAD A STRONG PRESENCE AT THE 10TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE (IAS 2019) IN MEXICO CITY IN JULY. TREAT ASIA DIRECTOR DR. ANNETTE SOHN CO-CHAIRED A SPECIAL SESSION WITH FORMER IAS PRESIDENT DR. CHRIS BEYRER OF JOHNS HOPKINS UNIVERSITY, CALLED "DATA LEADING THE WAY: DESIGNING RESPONSES BASED ON THE NUMBERS." DR. SOHN WAS ALSO A SESSION CO-CHAIR AT THE INTERNATIONAL WORKSHOP ON HIV PEDIATRICS, WHICH CONVENED IMMEDIATELY BEFORE IAS 2019. GITEN KHWAIRAKPAM, TREAT ASIA'S PROJECT MANAGER FOR COMMUNITY AND POLICY, CO-CHAIRED THE 5TH INTERNATIONAL HIV/VIRAL HEPATITIS CO-INFECTION PRECONFERENCE.
PROGRAM SERVICE ACCOMPLISHMENTS (2) CONT.	APACC TREAT ASIA WAS ALSO WELL REPRESENTED AT THE FOURTH ASIA PACIFIC AIDS & CO-INFECTIONS CONFERENCE (APACC), HELD IN JUNE 2019 IN HONG KONG. SEVERAL JUNIOR INVESTIGATORS AND PH.D. STUDENTS AFFILIATED WITH THE TREAT ASIA NETWORK GAVE ORAL AND POSTER PRESENTATIONS AT THE CONFERENCE. APACC IS A REGIONAL-LEVEL HIV RESEARCH CONFERENCE THAT PROVIDES OPPORTUNITIES FOR LOCAL CLINICIANS, STUDENTS, AND RESEARCHERS TO SUBMIT ABSTRACTS FOR PRESENTATION.
PROGRAM SERVICE ACCOMPLISHMENTS (3)	LINE 4C: PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT HIV-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. EDUCATIONAL MATERIALS AMFAR PRODUCES A RANGE OF PERIODICALS IN BOTH PRINT AND ELECTRONIC FORMATS, INCLUDING ITS NEWSLETTER INNOVATIONS, PUBLISHED TWICE A YEAR AND DISTRIBUTED TO MORE THAN 40,000 PEOPLE; THE TREAT ASIA REPORT, AN EMAIL NEWSLETTER DISTRIBUTED SIX TIMES A YEAR TO MORE THAN 4,000 READERS IN THE INTERNATIONAL HEALTH COMMUNITY; AND A MONTHLY E-MAIL NEWSLETTER DISTRIBUTED TO APPROXIMATELY 11,000 PEOPLE. IN 2019, AMFAR REMOVED OUTDATED ADDRESSES FROM ITS EMAIL LIST AND SIGNIFICANTLY IMPROVED ENGAGEMENT WITH ITS AUDIENCE. THE MONTHLY OPEN RATE INCREASED FROM AN AVERAGE OF ABOUT 10% TO 30%. THE FOUNDATIONS WEBSITES-WWW.AMFAR.ORG AND WWW.CURECOUNTDOWN.ORG-FEATURE NEWS, INTERVIEWS, AND ORIGINAL ARTICLES COVERING HIV RESEARCH, POLICY, THE GLOBAL EPIDEMIC, AND AMFAR PROGRAMS AND ACTIVITIES. THE WEBSITES ATTRACT A COMBINED AVERAGE OF 36,000 VISITORS PER MONTH. AMFAR ALSO CREATES AND DISTRIBUTES REPORTS, PRESS RELEASES, AND UPDATES ON MAJOR HIV/AIDS ISSUES AND CONDUCTS PUBLIC SERVICE ADVERTISING CAMPAIGNS THAT HAVE BEEN INSTRUMENTAL IN EDUCATING POLICYMAKERS, HEALTHCARE PROFESSIONALS, PEOPLE LIVING WITH HIV/AIDS, AND THE PUBLIC. PUBLIC POLICY AMFARS PUBLIC INFORMATION TEAM WORKS CLOSELY WITH THE PUBLIC POLICY OFFICE (SEE ABOVE) TO PRODUCE A WIDE RANGE OF ISSUE BRIEFS, FACTS SHEETS, INFOGRAPHICS, AND REPORTS. IN 2019 IT ALSO WORKED WITH AN ANIMATION STUDIO TO PRODUCE A SHORT FILM SHOWCASING THE FEATURES AND FUNCTIONALITY OF AMFARS OPIOID & HEALTH INDICATORS DATABASE (OPIOID.AMFAR.ORG). EPIC VOICES AMFARS EPIC VOICES, AN ONLINE VIDEO SERIES THAT AIMS TO REENERGIZE THE RESPONSE TO HIV AMONG MILLENNIAL AND LGBTQ COMMUNITIES CONTINUED TO GENERATE SIGNIFICANT PUBLICITY WITH SEVERAL NEW STORIES PUBLISHED IN 2019. LAUNCHED IN 2017, THE GOALS OF THE CAMPAIGN ARE TO: RENEW AWARENESS OF THE PERSISTENT THREAT OF HIV, UNDERSCORE THE URGENT NEED TO SUPPORT HIV RESEARCH, AND SUPPORT AMFARS LEADERSHIP IN THE SEARCH FOR A CURE. AMFAR SPOKE TO HIV ACTIVISTS ACROSS THE COUNTRY AND ASKED THEM TO SHARE THEIR UNIQUE JOURNEYS, THEIR INSIGHTS ON LIVING WITH HIV, AND THE BOLD STEPS THEY HAVE TAKEN IN THE FIGHT AGAINST THE EPIDEMIC. SOCIAL MEDIA AMFAR HAS VIGOROUSLY EXPANDED ITS PRESENCE IN THE SOCIAL MEDIA ARENA, REACHING LARGE NUMBERS OF PEOPLE, INCLUDING A YOUNGER DEMOGRAPHIC THAT IS OFTEN LESS EDUCATED ABOUT HIV AND THE AIDS EPIDEMIC. THE FOUNDATION REGULARLY ADDS CONTENT TO ITS FACEBOOK PAGE, LIVE TWEETS FROM EVENTS, AND POSTS IMAGES ON INSTAGRAM FROM FUNDRAISING AND PROGRAM EVENTS. AMFAR HAS 73,000 LIKES ON FACEBOOK, MORE THAN 43,000 TWITTER FOLLOWERS, AND 164,000 INSTAGRAM FOLLOWERS. MEDIA OUTREACH IN FY2019, AMFAR CONTINUED TO WORK CLOSELY WITH THE MEDIA TO RAISE THE PROFILE OF HIV/AIDS, BOTH DOMESTICALLY AND INTERNATIONALLY, AND TO HELP ENSURE THE ACCURACY OF HIV-RELATED PRESS COVERAGE. ARTICLES AND REPORTS INVOLVING AMFAR-MANY OF WHICH INCLUDED INTERVIEWS WITH STAFF-WERE CARRIED IN NUMEROUS MEDIA OUTLETS, INCLUDING THE NEW YORK TIMES, WIRED, SCIENCE, THE WASHINGTON POST, BANGKOK POST, USA TODAY, U.S. NEWS & WORLD REPORT, PEOPLE, VOX, VOGUE, VANITY FAIR, ESSENCE, BUSTLE, THE ADVOCATE, POZ, CBS NEWS, NBC NEWS, ABC NEWS, FOX NEWS, NPR, ASSOCIATED PRESS, AND REUTERS. CELEBRITY SUPPORT AMFARS PUBLIC AWARENESS EFFORTS ARE GREATLY ENHANCED BY THE COMMITTED SUPPORT OF PUBLIC FIGURES WHO LEND THEIR VOICES AND DONATE THEIR TIME, TALENTS, AND RESOURCES TO HELP SUSTAIN THE FOUNDATIONS MISSION. SUPPORT OF AMFAR BY PROMINENT PUBLIC FIGURES BEGAN WITH THE LATE DAME ELIZABETH TAYLOR, AMFARS FOUNDING INTERNATIONAL CHAIRMAN, AND OTHERS HAVE FOLLOWED IN HER FOOTSTEPS. AMFAR IS PROFOUNDLY GRATEFUL FOR THE CONTINUING SUPPORT OF CELEBRITIES FROM ALL OVER THE WORLD. CELEBRITY SUPPORTERS INCLUDED KATY PERRY, DAME SHIRLEY BASSEY, DARREN CRISS, JUDD APATOW, ROBERT PATTINSON, MATT BOMER, DIANA ROSS, JAY ELLIS, ZOE SALDANA, GRACE JONES, MILLA JOVOVICH, MERT ALAS AND MARCUS PIGGOTT, KIM KARDASHIAN, KOURTNEY KARDASHIAN, HEIDI KLUM, ALAN CUMMING, MICHELLE RODRIGUEZ, KAROLINA KURKOVA, ALESSANDRA AMBROSIO, CAROLINE VREELAND, CANDICE SWANEPOEL, ELSA HOSK, KAREN ELSON, LAIS RIBEIRO, VICTORIA JUSTICE, WINNIE HARLOW, ALEXANDER SKARSGRD, PHARRELL WILLIAMS, MICHELLE YEOH, KYLE MACLACHLAN, NICOLE SCHERZINGER, LAY ZHANG, MARIAH CAREY, DUA LIPA, TOM JONES, CHARLI XCX, CHRIS TUCKER, CARINE ROITFELD, ANDREAS SCHAGER, HENRY GOLDING, EVA LONGORIA, ANDIE MACDOWELL, NATASHA POLY, PATRICIA ARQUETTE, ANTONIO BANDERAS, ORLANDO BLOOM, IAN BOHEN, ADRIEN BRODY, KENDALL JENNER, H.E.R., TOMMY HILFIGER, KRIS JENNER, JULIAN LENNON, ADRIANA LIMA, COCO ROCHA, SARA SAMPAIO, CHRISTOPH WALTZ, REBEL WILSON, CEELO GREEN, JOAN SMALLS, AND RITA ORA.
PROGRAM SERVICE ACCOMPLISHMENTS (5)	LINE 4D: PUBLIC POLICY: INFORMED BY THOROUGH RESEARCH AND ANALYSIS, AMFAR IS A HIGHLY RESPECTED ADVOCATE OF RATIONAL AND COMPASSIONATE HIV/AIDS-RELATED PUBLIC POLICY. THE FOUNDATION IS ENGAGED IN EFFORTS TO SECURE NECESSARY INCREASES IN FUNDING FOR HIV/AIDS RESEARCH AND GLOBAL HIV/AIDS PROGRAMS, EXPAND ACCESS TO TREATMENT AND CARE FOR MARGINALIZED POPULATIONS, ADVOCATE HARM REDUCTION POLICIES AIMED AT REDUCING THE SPREAD OF HIV AND HEPATITIS C (HCV) AMONG PEOPLE WHO INJECT DRUGS, AND PROTECT THE CIVIL RIGHTS OF ALL PEOPLE AFFECTED BY OR VULNERABLE TO HIV/AIDS. ENDING THE DOMESTIC HIV EPIDEMIC DURING THE 2019 STATE OF THE UNION, PRESIDENT TRUMP ANNOUNCED A PLAN TO END HIV TRANSMISSIONS IN THE U.S. BY 2030. THE ENDING THE HIV EPIDEMIC INITIATIVE (EHE) AIMS TO REDUCE HIV INFECTIONS BY 75% IN FIVE YEARS, AND BY 90% IN TEN YEARS. IN 2019, AMFAR LAUNCHED A FREE INTERACTIVE DATABASE (EHE.AMFAR.ORG) TO HELP POLICYMAKERS, PUBLIC HEALTH OFFICIALS, ADVOCATES, AND OTHER STAKEHOLDERS UNDERSTAND THE OPPORTUNITIES AND CHALLENGES ACROSS EHE JURISDICTIONS. THE EHE DATABASE INCLUDES DEMOGRAPHIC, POLICY, AND SERVICE PROVIDER INFORMATION, AND EPIDEMIOLOGICAL INDICATORS. IN 2018 THE TRUMP ADMINISTRATION PROPOSED A RULE CHANGE TO THE TITLE X NATIONAL FAMILY PLANNING PROGRAM, STATING THAT HEALTH PROVIDERS IN THE TITLE X PROGRAM "MAY NOT PERFORM, PROMOTE, REFER FOR, OR SUPPORT ABORTION." THE STIPULATION IS COMMONLY KNOWN AS THE DOMESTIC GAG RULE. IN FEBRUARY 2019, AMFAR PUBLISHED TITLE X, THE DOMESTIC GAG RULE, AND THE HIV RESPONSE, AN ISSUE BRIEF ILLUSTRATING THE BENEFITS OF THE TITLE X PROGRAM AND POTENTIAL IMPACTS OF THE GAG RULE. ANALYSIS FROM THE REPORT SHOWS THAT, IF IMPLEMENTED, THE DOMESTIC GAG RULE COULD NOT ONLY UNDERMINE WOMENS ACCESS TO REPRODUCTIVE HEALTH SERVICES, BUT ALSO IMPEDE ACCESS TO HIV TESTING FOR LOW-INCOME POPULATIONS, THREATENING THE NATIONAL RESPONSE TO THE HIV EPIDEMIC. AND IN MARCH 2019, AMFAR PUBLISHED AN ISSUE BRIEF TITLED EXPANDING ACCESS TO PRE-EXPOSURE PROPHYLAXIS (PREP) FOR ADOLESCENTS AND YOUNG ADULTS: MODELS FOR ADDRESSING CONSENT, CONFIDENTIALITY, AND PAYMENT BARRIERS. ENSURING THAT ADOLESCENTS AND YOUNG ADULTS AT RISK FOR HIV CAN ACCESS PREP IS A KEY STEP TOWARD REDUCING THE NUMBER OF HIV DIAGNOSES. HIV AND THE OPIOID EPIDEMIC AMFAR MAINTAINS AN IMPORTANT AND WIDELY USED RESOURCE ON HIV AND THE OPIOID EPIDEMIC. ITS OPIOID & HEATH INDICATORS DATABASE (OPIOID.AMFAR.ORG) IS A FREE WEB PLATFORM DESIGNED TO SUPPORT LAWMAKERS, COMMUNITIES AND ADVOCATES IN MAKING INFORMED DECISIONS ABOUT THE OPIOID EPIDEMIC AND ITS IMPACT ON HIV AND HEPATITIS C. THE SITE IS A WINDOW INTO THE OPIOID EPIDEMIC UNFOLDING IN EVERY AMERICANS BACKYARD. IT PROVIDES LOCAL TO NATIONAL STATISTICS USING RELIABLE DATA SOURCES ON NEW HIV AND HEPATITIS C INFECTIONS, OPIOID USE AND OVERDOSE DEATH RATES, AND THE AVAILABILITY OF SERVICES LIKE DRUG TREATMENT PROGRAMS AND SYRINGE EXCHANGE SERVICES. IN OCTOBER 2018, AMFAR PUBLISHED AN ANALYSIS IN HEALTH AFFAIRS ON THE LOW PERCENTAGE OF SUBSTANCE USE FACILITIES THAT TEST FOR HIV OR HEPATITIS C. THE NEW YORK TIMES PUBLISHED SEVERAL ARTICLES HIGHLIGHTING THE BIPARTISAN OPIOID BILL PASSED BY CONGRESS THAT LINKED TO AMFARS ORIGINAL HEALTH AFFAIRS ANALYSIS ON THE DEARTH OF SUBSTANCE USE TREATMENT FACILITIES THAT OFFER MEDICATION-ASSISTED TREATMENT (MAT) NATIONWIDE. THE NUMBER OF DRUG-RELATED POISONING DEATHS IN THE UNITED STATES MORE THAN TRIPLED BETWEEN 1999 AND 2017, ACCOMPANIED BY A RISE IN INJECTION DRUG USE. SINCE UPTAKE OF TREATMENT FOR SUBSTANCE USE DISORDER AND HARM REDUCTION SERVICES AT SYRINGE SERVICES PROGRAMS (SSPS) CAN REDUCE THE RISK OF HIV AND HEPATITIS C ACQUISITION, ACCESS TO SERVICES IS CRITICALLY IMPORTANT. IN NOVEMBER 2018, AMFAR PUBLISHED GETTING TO SERVICES: FAR, FAR AWAY, AN INFOGRAPHIC SHOWING HOW FAR AMERICANS MUST TRAVEL TO SUBSTANCE USE CLINICS OFFERING MAT AND SSPS. NEARLY 30% OF AMERICANS LIVE MORE THAN TEN MILES FROM A FACILITY PROVIDING MEDICATION-ASSISTED TREATMENT, AND NEARLY 80% LIVE MORE THAN TEN MILES FROM AN SSP. ACCORDING TO ONE STUDY, PEOPLE TYPICALLY DO NOT ACCESS SSPS IF THEY ARE MORE THAN TEN MILES FROM WHERE THEY LIVE. IN AUGUST 2019, AMFAR SENIOR POLICY AND MEDICAL ADVISOR DR. SUSAN BLUMENTHAL PENNED AN OP-ED ON THRIVEGLOBAL ON THE NEED FOR A STRATEGIC PLAN FOR ADDRESSING THE OPIOID EPIDEMIC PARALLELING WHAT WAS DONE FOR HIV. GLOBAL HEALTH IN OCTOBER 2018, AMFAR PUBLISHED A FIRST-OF-ITS-KIND ANALYSIS THAT ATTEMPTED TO QUANTIFY INDIRECT COSTS CHARGED BY ORGANIZATIONS IMPLEMENTING THE U.S. PRESIDENTS EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR). EXAMINING DATA FROM 2007 TO 2016, THE STUDY FOUND THAT BETWEEN $1.85 BILLION AND $4.34 BILLION WAS SPENT ON INDIRECT COSTS. THE STUDY WAS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL PLOS ONE, AND CALLED FOR INCREASED TRANSPARENCY IN REPORTING INDIRECT COSTS INCURRED BY PEPFAR. AT THE BIENNIAL HIV RESEARCH FOR PREVENTION CONFERENCE IN MADRID IN OCTOBER 2018, AMFAR POLICY ASSOCIATE JENNIFER SHERWOOD AND COLLEAGUES PRESENTED FINDINGS FROM A SURVEY USED TO TRACK THE IMPACT OF THE EXPANDED MEXICO CITY POLICY ON THE OPERATIONS AND SERVICE DELIVERY OF ORGANIZATIONS RECEIVING ASSISTANCE THROUGH PEPFAR. THE MEXICO CITY POLICY, OR "GLOBAL GAG RULE," WAS REINSTATED AND EXPANDED BY PRESIDENT TRUMP IN 2017. IT NOW RESTRICTS NON-U.S.-BASED OR FOREIGN NGOS FROM RECEIVING AMERICAN FINANCIAL AID IF THEY PERFORM, COUNSEL ON, OR REFER FOR ABORTION, OR ADVOCATE FOR ITS LIBERALIZATION OUTSIDE OF LIMITED EXCEPTIONS. IN JANUARY 2019, AMFAR PUBLISHED AN ISSUE BRIEF REPORTING ON DISRUPTIONS IN SERVICE PROVISION DUE TO THE EXPANDED MEXICO CITY POLICY. BASED ON THE SURVEY DESCRIBED ABOVE, AMFAR REVEALED THAT PEPFAR PARTNERS IN 31 COUNTRIES REPORTED DISRUPTIONS IN SERVICE PROVISION DUE TO THE POLICY. THESE FINDINGS HAVE SERIOUS IMPLICATIONS FOR REPRODUCTIVE HEALTH AND THE GLOBAL HIV EPIDEMIC. IN FEBRUARY 2019, AMFAR PUBLISHED A COMPANION INFOGRAPHIC, PEPFAR PROGRAMMING DISRUPTED BY EXPANDED MEXICO CITY POLICY. IN DECEMBER 2018, AMFAR LAUNCHED THE PEPFAR MONITORING, EVALUATION, AND REPORTING (MER) DATABASE (MER.AMFAR.ORG). THE MER DATABASE ENABLES POLICYMAKERS, PUBLIC HEALTH OFFICIALS, ADVOCATES, AND OTHER STAKEHOLDERS TO ACCESS A WIDE RANGE OF PROGRAMMATIC PEPFAR DATA AND INCLUDES DOWNLOADABLE PDFS, MAPS, DATA VISUALIZATIONS, AND DISTRICT-LEVEL DATA. THE NEW DATABASE COMPLEMENTS AMFARS EXISTING PEPFAR DATABASE (COPSDATA.AMFAR.ORG), WHICH HIGHLIGHTS PLANNED FUNDING BY PROGRAM AREA, COUNTRY AND ORGANIZATION FOR EACH YEAR THAT HAS BEEN PUBLICLY RELEASED. THE DATABASE IS DESIGNED TO HELP PEPFAR IN ITS EFFORTS TO INCREASE DATA TRANSPARENCY AND GENERAL PARTICIPATION IN THE PLANNING PROCESS. IN FEBRUARY 2019, AMFAR, IN CONJUNCTION WITH AVAC, PUBLISHED AN ISSUE BRIEF TITLED NEW HIV TESTING STRATEGIES IN PEPFAR COP19: ROLLOUT AND HUMAN RIGHTS CONCERNS. THE REPORT ANALYZES COUNTRY OPERATIONAL PLAN (COP) GUIDANCE FOR HIV TESTING AND RECOMMENDED POLICIES AIMED AT HELPING TO FIND HIV-POSITIVE PEOPLE WHO HAVE NOT BEEN IDENTIFIED BY OTHER TESTING PROGRAMS AND LINKING THEM TO TREATMENT. IN MAY 2019, AMFAR PUBLISHED A PAIR OF INFOGRAPHICS DEMONSTRATING THE EFFECTIVENESS OF THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA: A GLOBAL RESPONSE TO HIV REQUIRES THE GLOBAL FUND AND HOW THE GLOBAL FUND IMPROVES PEPFAR INVESTMENTS. THE TWO ORGANIZATIONS ARE THE WORLDS LARGEST AND MOST EFFECTIVE INVESTORS IN HIV TREATMENT AND PREVENTION. IAS 2019 AMFARS PUBLIC POLICY OFFICE PARTICIPATED IN THE 10TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE (IAS 2019) IN MEXICO CITY IN JULY. AMFAR VICE PRESIDENT AND DIRECTOR OF PUBLIC POLICY GREG MILLETT JOINED DR. ANTHONY FAUCI, DIRECTOR OF THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AT A PRESS CONFERENCE ON "TRANSLATING PROGRESS INTO SUCCESS TO END THE AIDS EPIDEMIC." THE PRESS CONFERENCE COINCIDED WITH THE RELEASE OF A REPORT WITH THE SAME NAME, COAUTHORED BY AMFAR, AVAC, AND FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA. THE REPORT SHOWS PLACES ACROSS THE GLOBAL NORTH AND SOUTH ON TRACK TO END THEIR RESPECTIVE EPIDEMICS AND THE COMMONALITIES BETWEEN THEM. MR. MILLETT ALSO SPOKE AT A JOURNALIST ROUNDTABLE SPONSORED BY AVAC, AND SHARED THE STAGE AT A SEPARATE MEETING WITH WORLD HEALTH ORGANIZATION REPRESENTATIVES AND AMBASSADOR DEBORAH BIRX, U.S. GLOBAL AIDS COORDINATOR, TO DEBATE THE ETHICS OF HIV RECENCY TESTING IN PEPFAR PROGRAMS.
THE GMT INITIATIVE	IMPLEMENTATION SCIENCE AWARDS IN FY2019, AMFARS GRANT MAKING THROUGH THE GMT INITIATIVE CONTINUED TO SUPPORT TWO LARGE IMPLEMENTATION SCIENCE PROJECTS AIMED AT IDENTIFYING BARRIERS TO HIV TESTING, TREATMENT, AND CARE AND STUDYING THE IMPACT OF INNOVATIVE HIV SERVICE DELIVERY MODELS FOR GAY MEN, OTHER MEN WHO HAVE SEX WITH MEN, AND TRANSGENDER INDIVIDUALS (COLLECTIVELY, GMT) IN LOW- AND MIDDLE-INCOME COUNTRIES. AMFAR HAS AWARDED $2.6 MILLION OVER THREE YEARS TO SUPPORT THE STUDIES. DR. CHRIS BEYRER OF JOHNS HOPKINS UNIVERSITY IN BALTIMORE IS LEADING A TEAM OF RESEARCHERS AND COMMUNITY-BASED SERVICES (IN COLLABORATION WITH THE INTERNATIONAL HIV/AIDS ALLIANCE MYANMAR) IN EVALUATING THE EFFECTIVENESS OF PROMISING INTERVENTIONS FOR GMT IN MYANMAR, WHERE INCREASED HIV TESTING AND TREATMENT OPPORTUNITIES ARE BECOMING AVAILABLE. THE RESEARCHERS ARE ASSESSING THE EFFECTIVENESS OF HIV SELF-TESTING DONE IN THE PRIVACY OF ONES HOME, POINT-OF-CARE CD4 TESTING, AND THE USE OF "PEER NAVIGATORS" FAMILIAR WITH THE LOCAL HEALTH SYSTEM TO HELP THOSE NEWLY DIAGNOSED GAIN ACCESS TO HIV TREATMENT AND CARE. IN BANGKOK, DR. NITTAYA PHANUPHAK AND HER TEAM AT THE THAI RED CROSS AIDS RESEARCH CENTRE ARE WORKING TO SHOW HOW INNOVATIVE TECHNOLOGIES SUCH AS GMT-TARGETED WEBSITES USING ONLINE COUNSELING AND SUPPORT CAN BE UTILIZED TO INCREASE RATES OF HIV TESTING AND REFERRALS TO PREVENTION AND TREATMENT PROGRAMS. WORKING IN COLLABORATION WITH ADAMS LOVE, A WEB-BASED HEALTH PLATFORM FOR GMT INDIVIDUALS, AND TWO COMMUNITY-BASED ORGANIZATIONS (SERVICE WORKERS IN GROUP/SWING AND THE RAINBOW SKY ASSOCIATION OF THAILAND), THE TEAM IS COMPARING THE EFFECTIVENESS OF ONLINE SERVICES AND SUPPORT INTERVENTIONS WITH TRADITIONAL CLINIC-BASED HIV SERVICES, AND A HYBRID MODEL THAT COMBINES ELEMENTS OF BOTH STRATEGIES.
POLICIES	FORM 990, PART VI, SECTION B LINE 11 - THE FORM 990 WAS PREPARED BY A NATIONALLY RENOWNED ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. A COPY OF THE DRAFT FORM 990 WAS CIRCULATED TO THE FULL BOARD OF TRUSTEES FOR DISCUSSION AND COMMENT. EACH BOARD MEMBER WAS PROVIDED AMPLE OPPORTUNITY TO COMMENT ON THE INFORMATION CONTAINED IN THE 990 PRIOR TO ITS FILING WITH THE INTERNAL REVENUE SERVICE. LINE 12 - EACH OFFICER, DIRECTOR, TRUSTEE AND KEY EMPLOYEE OF AMFAR ("FOUNDATION") IS REQUIRED TO ANNUALLY DISCLOSE ANY CONFLICTS OF INTEREST THAT ARISE BY VIRTUE OF EMPLOYMENT, BOARD SERVICE, OR POSITION WITH THE FOUNDATION. THE FOUNDATION MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY THROUGH AN ANNUAL QUESTIONNAIRE/DISCLOSURE STATEMENT THAT IS DISTRIBUTED TO THESE INDIVIDUALS. POTENTIAL CONFLICTS ARE INVESTIGATED IMMEDIATELY. LINE 15 - AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS. AMFAR'S last independent compensation study was conducted in November of 2019 to ensure that the President & CEO's compensation is reasonable given the market in which the Foundation operates.
DISCLOSURE	FORM 990, PART VI, SECTION C LINE 19 - AMFAR MAKES ITS FORM 990 AVAILABLE TO THE PUBLIC BY RETAINING A COPY AT ITS PLACE OF BUSINESS AND ON ITS WEBSITE, WWW.AMFAR.ORG. THE FORM 990 IS LIKEWISE PUBLISHED ON THE INTERNET AT WWW.GUIDESTAR.ORG. THE FOUNDATION'S FINANCIAL STATEMENTS ARE MADE AVAILABLE IN ITS ANNUAL REPORT AND ON ITS WEBSITE. THE FOUNDATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT ORDINARILY MADE AVAILABLE TO THE PUBLIC, BUT, IF REQUESTED, WILL BE PROVIDED AT MANAGEMENT'S DISCRETION.
FUNCTIONAL EXPENSES	PART IX, LINES 1 & 3 THE FOUNDATION FOR AIDS RESEARCH REPORTS ITS GRANTS NET OF GRANT RETURNS OR RECOVERIES. PERIODICALLY, GRANTS REMITTED TO CHARITABLE ORGANIZATIONS ARE RETURNED TO AMFAR FOR A VARIETY OF REASONS. ON SCHEDULES F & I, GRANTS ARE REPORTED IRRESPECTIVE OF WHETHER THEY WERE ULTIMATELY RETURNED TO AMFAR SINCE CATEGORIZING THE "RETURNED" AMOUNTS WOULD BE TIME CONSUMING. THEREFORE, AMOUNTS REPORTED ON PART IX, LINE 1 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE I; AMOUNTS REPORTED ON PART IX, LINE 3 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE F.

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2018

Additional Data

Software ID:
Software Version:

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	42,784,390	40,275,703
9	Program service revenue (Part VIII, line 2g) .........	0	0
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	1,668,073	2,262,943
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	-12,144,387	-11,197,256
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)	32,308,076	31,341,390
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	12,574,033	10,109,752
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	11,259,330	11,146,319
16a	Professional fundraising fees (Part IX, column (A), line 11e) .....	735,053	747,847
b	Total fundraising expenses (Part IX, column (D), line 25) 5,823,450
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	14,468,481	12,968,286
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	39,036,897	34,972,204
19	Revenue less expenses. Subtract line 18 from line 12.......	-6,728,821	-3,630,814
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	69,536,136	64,157,103
21	Total liabilities (Part X, line 26).............	16,985,457	14,672,542
22	Net assets or fund balances. Subtract line 21 from line 20.....	52,550,679	49,484,561

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 15,340,994 including grants of $ 8,045,603 ) (Revenue $ 0 )
	RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. FOR FURTHER DETAILS, SEE SCHEDULE O.

4b	(Code: ) (Expenses $ 4,670,239 including grants of $ 1,891,311 ) (Revenue $ 0 )
	TREAT ASIA: AMFARS TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF TREATMENTS FOR HIV AND ITS CO-INFECTIONS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. FOR FURTHER DETAILS, SEE SCHEDULE O.

4c	(Code: ) (Expenses $ 4,097,084 including grants of $ 0 ) (Revenue $ 0 )
	PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT HIV-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. FOR FURTHER DETAILS, SEE SCHEDULE O.

	(Code: ) (Expenses $ 2,049,139 including grants of $ 77,995 ) (Revenue $ 0 )
	public policy

	(Code: ) (Expenses $ 268,341 including grants of $ 94,843 ) (Revenue $ 0 )
	GMT Initiative

4d	Other program services (Describe in Schedule O.)
	(Expenses $ 2,317,480 including grants of $ 172,838 ) (Revenue $ 0 )
4e	Total program service expenses26,425,797

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)...........	2,876,091	0	659,396

1a	Federated campaigns..		1a	90,281
b	Membership dues..		1b
c	Fundraising events..		1c	27,896,470
d	Related organizations		1d
e	Government grants (contributions)		1e	6,017,798

f	All other contributions, gifts, grants, and similar amounts not included above		1f	6,271,154

g	Noncash contributions included in lines 1a - 1f:$ 63,158
h Total. Add lines 1a-1f.......		40,275,703

1	Briefly describe the organization’s mission or most significant activities: AMFAR IS DEDICATED TO ENDING THE GLOBAL AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	12
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	12
5	Total number of individuals employed in calendar year 2018 (Part V, line 2a) ......	5	94
6	Total number of volunteers (estimate if necessary) .............	6	0
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b	0

		Business Code
2a
b
c
d
e
f	All other program service revenue.
g	Total. Add lines 2a–2f ....		0

3 Investment income (including dividends, interest, and othersimilar amounts) ......			1,492,677		1,492,677
4 Income from investment of tax-exempt bond proceeds			0
5 Royalties...........			45,654		45,654
		(ii) Personal	(i) Real
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)	0	0
d	Net rental income or (loss)......			0
		(ii) Other	(i) Securities
7a	Gross amount from sales of assets other than inventory	1,455	23,533,474
b	Less: cost or other basis and sales expenses		22,764,663
c	Gain or (loss)	1,455	768,811
d	Net gain or (loss).....			770,266		770,266
8a	Gross income from fundraising events (not including $ 27,896,470of contributions reported on line 1c). See Part IV, line 18 ....
	a		1,794,170
b	Less: direct expenses ...b		13,056,389
c	Net income or (loss) from fundraising events..			-11,262,219		-11,262,219
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a		0
b	Less: direct expenses ...b		0
c	Net income or (loss) from gaming activities..			0
10a	Gross sales of inventory, less returns and allowances ..
	a		25,294
b	Less: cost of goods sold ..b		9,281
c	Net income or (loss) from sales of inventory..			16,013		16,013
Business Code			Miscellaneous Revenue
11a	STORE SALES		900099	1,859		1,859
b	LIST RENTALS		900099	170		170
c	MISCELLANEOUS INCOME		900099	1,267		1,267
d	All other revenue ....
e	Total. Add lines 11a–11d ......			3,296
12	Total revenue. See Instructions......			31,341,390		-8,934,313

1	Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21	6,879,084	6,879,084
2	Grants and other assistance to domestic individuals. See Part IV, line 22	0
3	Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, line 15 and 16.	3,230,668	3,230,668
4	Benefits paid to or for members	0
5	Compensation of current officers, directors, trustees, and key employees ....	2,522,218	1,837,955	326,246	358,017
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....	0
7	Other salaries and wages	6,087,863	4,025,651	676,870	1,385,342
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	378,518	247,419	43,798	87,301
9	Other employee benefits .......	1,637,261	1,057,777	229,336	350,148
10	Payroll taxes ...........	520,459	336,756	65,216	118,487
11	Fees for services (non-employees):
a	Management ......	0
b	Legal .........	-4,808	-9,150	4,324	18
c	Accounting ...........	196,725		196,725
d	Lobbying ...........	123,466	123,466
e	Professional fundraising services. See Part IV, line 17	747,847			747,847
f	Investment management fees ......	277,449		277,449
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O)	1,366,933	907,234	34,283	425,416
12	Advertising and promotion ....	346,932	309,763	1,993	35,176
13	Office expenses .......	68,296	41,715	7,387	19,194
14	Information technology ......	205,549	155,635	21,016	28,898
15	Royalties ..	0
16	Occupancy ...........	1,517,346	1,086,453	171,818	259,075
17	Travel ............	1,236,674	476,254	2,221	758,199
18	Payments of travel or entertainment expenses for any federal, state, or local public officials .	0
19	Conferences, conventions, and meetings ....	510,065	493,801	4,190	12,074
20	Interest ...........	0
21	Payments to affiliates .......	0
22	Depreciation, depletion, and amortization ..	446,165	324,244	51,322	70,599
23	Insurance ...	364,337	264,776	41,910	57,651
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	PROGRAM MATERIALS	2,230,607	2,230,607
b	PROGRAM TECHNICAL SUPPORT	836,863	836,863
c	BAD DEBT EXPENSE	631,150	458,679	72,601	99,870
d	PRINTING	550,024	121,353	1,072	427,599
e	All other expenses	2,064,513	988,794	493,180	582,539
25	Total functional expenses. Add lines 1 through 24e	34,972,204	26,425,797	2,722,957	5,823,450
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).	518,072	156,353	0	361,719

1	Cash–non-interest-bearing ........			5,477,346	1	6,826,913
2	Savings and temporary cash investments .........			691,606	2	1,423,450
3	Pledges and grants receivable, net ......			699,100	3	867,952
4	Accounts receivable, net .............			6,388,976	4	6,339,168
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L .............
				0	5	0
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L ..............
				0	6	0
7	Notes and loans receivable, net ....			0	7	0
8	Inventories for sale or use ........			425,761	8	413,307
9	Prepaid expenses and deferred charges ......			1,960,938	9	2,003,877
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	7,298,048
b	Less: accumulated depreciation	10b	4,497,236	2,921,534	10c	2,800,812
11	Investments—publicly traded securities .			48,872,134	11	42,758,997
12	Investments—other securities. See Part IV, line 11 .....			0	12	0
13	Investments—program-related. See Part IV, line 11 ..			0	13	0
14	Intangible assets ...............			0	14	0
15	Other assets. See Part IV, line 11 ...........			2,098,741	15	722,627
16	Total assets. Add lines 1 through 15 (must equal line 34)...			69,536,136	16	64,157,103

17	Accounts payable and accrued expenses .....	3,655,122	17	2,769,299
18	Grants payable ...	2,768,840	18	2,086,068
19	Deferred revenue .........	8,596,427	19	7,947,789
20	Tax-exempt bond liabilities .........	0	20	0
21	Escrow or custodial account liability. Complete Part IV of Schedule D	0	21	0
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..	0	22	0
23	Secured mortgages and notes payable to unrelated third parties ..	0	23	0
24	Unsecured notes and loans payable to unrelated third parties ..	0	24	0
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D	1,965,068	25	1,869,386
26	Total liabilities. Add lines 17 through 25..	16,985,457	26	14,672,542

	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets	48,668,968	27	45,254,909
28	Temporarily restricted net assets ...........	3,509,128	28	3,850,319
29	Permanently restricted net assets	372,583	29	379,333
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds .....		30
31	Paid-in or capital surplus, or land, building or equipment fund ...		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	52,550,679	33	49,484,561
34	Total liabilities and net assets/fund balances ........	69,536,136	34	64,157,103

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No